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ABSTRACT OF THE DISSERTATION

Genomic Analysis of Human Spinal Deformity and Characterization
of a Zebrafish Disease Model
by
Jillian Gwen Buchan
Doctor of Philosophy in Biology & Biomedical Sciences
Molecular Genetics and Genomics
Washington University in St. Louis, 2014
Associate Professor Christina Gurnett, Chair

Scoliosis is characterized by a lateral curvature of the spine that requires long-term
bracing and invasive spinal surgery in cases with progressive deformity. Some individuals
develop scoliosis secondary to congenital malformations or syndromic disorders, but most
scoliosis is considered idiopathic and has no known cause. Adolescent idiopathic scoliosis (AIS)
onsets in late childhood and causes spinal deformity in approximately 3% of the pediatric
population. Despite a strong genetic basis, genetic risk factors for AIS are unknown and the
pathogenesis remains poorly understood, which has been further hindered by the lack of a
relevant animal model. Therefore, we used multiple approaches to better understand the genetic
and molecular etiology of AIS using human and animal-based studies.
First, we performed copy number variation analysis on 143 patients with isolated
scoliosis using the Affymetrix Genome-wide Human SNP Array 6.0.

We identified a

duplication of chromosome 1q21.1 in 2.1% (N=3/143) of AIS patients, which was enriched
compared to 0.09% (N=1/1079) of controls (P=0.0057) and 0.07% (N=6/8329) of published

ix

controls (P=0.0004). Other notable findings include trisomy X, which was identified in 1.8%
(N=2/114) of female AIS patients, and rearrangements of chromosome 15q11.2 and 16p11.2 that
may be relevant to scoliosis susceptibility. We also report rare CNVs that will be of use to future
studies investigating candidate genes for AIS.
Second, we performed a genome-wide rare variant burden analysis using exome sequence
data and identified FBN1 (fibrillin-1) as the most significantly associated gene with
AIS. Mutations in FBN1 are most frequently association with Marfan syndrome, a syndromic
condition that causes scoliosis in 60% of patients. Based on these results, FBN1 and a related
gene, FBN2 (fibrillin-2), were sequenced in a total of 852 AIS cases and 669 controls. In
individuals of European ancestry, rare variants in FBN1 and FBN2 were enriched in severely
affected AIS cases (7.6%) compared to in-house controls (2.4%) (OR=3.5, P=5.46×10-4) and
Exome Sequencing Project controls (2.3%) (OR=3.5, P=1.48×10-6). Scoliosis severity in AIS
cases was associated with FBN1 and FBN2 rare variants (P=0.0012) and replicated in an
independent Han Chinese cohort (P=0.0376), suggesting that rare variants have utility as
predictors of curve progression. Clinical evaluations revealed that the majority of AIS cases
with rare FBN1 variants do not meet diagnostic criteria for Marfan syndrome, though variants
are associated with tall stature (P=0.0035) and upregulation of the TGF-β pathway.
Finally, we characterized a recessive zebrafish mutant, called skolios, which develops a
spinal deformity phenotype that parallels many features of human AIS, including an isolated
lateral curvature of the spine that arises independent of congenital vertebral malformations.
Skolios was identified in a mutagenesis screen and previously mapped to a 2.7 Mb region on
chromosome 17. Because skolios may be an informative model of scoliosis, we sought to
identify its genetic basis. We performed low coverage whole genome sequencing on a skolios
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mutant and identified a single nonsense mutation in the mapped region, which caused a
premature stop in kinesin family member 6 (kif6), a poorly characterized kinesin of unknown
function. To determine if the loss of kif6 is responsible for the skolios phenotype, we used
TALENs to create additional mutant alleles. We isolated three new TALEN-induced mutations
that caused frameshift mutations in kif6. All zebrafish homozygous or compound heterozygous
for kif6 frameshift mutations developed body axis curvature that was indistinguishable from
skolios mutants, verifying kif6 as the causative gene.

Preliminary investigation into the

mechanism of spinal deformity revealed no association with vertebral malformations or cilia
defects in skolios mutants.
Overall, these results identify important genetic risk factors for AIS, including clinically
relevant copy number variants and rare genetic variation in FBN1 and FBN2. Moreover, we
have identified an animal model with scoliosis and demonstrated a novel role for kif6 in the
developing spine. These findings have significant impact on our understanding of the genetic
basis of AIS and reveal new strategies to identify and treat AIS.
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Chapter 1:
Introduction and Perspective

1

Scoliosis
Spinal deformity is a general term that encompasses several conditions where the spine is
abnormally curved or misaligned. Scoliosis is a form of spinal deformity that causes a complex,
three-dimensional curvature of the spine, with the predominate deviation from the midline
occurring in the frontal plane (Figure 1.1). Scoliosis is therefore quantified by the degree of
lateral curvature. The Cobb method is the standard and most reliable method of assessing the
magnitude of spinal curvature in scoliosis and is quantified by measuring the angle, also called
the Cobb angle, formed between lines drawn parallel to the most tilted vertebrae on a standing
radiograph (Figure 1.2) [1,2]. Slight variation in the curvature of the spine is normal in the
population; thus, pathological scoliosis is defined as curves measuring ≥10° using the Cobb
method [3].

Scoliosis classification
Scoliosis is classified by the associated etiology, if known, and can be divided into four
general categories: congenital, neuromuscular, syndromic and idiopathic (Table 1.1).

In

congenital scoliosis, spinal curvature is secondary to malformations of the vertebrae, such as
wedge-shaped vertebrae and hemivertebrae [4]. These vertebral malformations occur early in
development and are caused by defects during somatogenesis, which can result in imbalanced
spinal growth and scoliosis [5].
In neuromuscular and syndromic scoliosis, scoliosis arises secondary to a primary,
systemic condition. For example, scoliosis is common in certain neuromuscular conditions,
including 20-25% of patients with cerebral palsy [6] and 75-90% of patients with Duchenne’s
muscular dystrophy [7].

Similarly, scoliosis is a common feature of several syndromic
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conditions, including 63% of patients with Marfan syndrome [8], which also causes a variety of
other cardiovascular, pulmonary, ocular and skeletal phenotypes.
When congenital, neuromuscular and syndromic origins of scoliosis have been ruled out,
scoliosis is considered idiopathic. Idiopathic scoliosis is therefore a diagnosis of exclusion that
typically occurs as an isolated condition in otherwise healthy individuals. Approximately 80%
of all scoliosis is classified as idiopathic. Some patients with idiopathic scoliosis are identified
early in life (0-9 years). However, in the majority of cases, scoliosis is detected in late childhood
with progression coinciding with pubertal growth in adolescence. Thus, idiopathic scoliosis that
is identified in late childhood is further categorized as adolescent idiopathic scoliosis (AIS).

Adolescent idiopathic scoliosis
AIS affects up to 3% of all children and is generally defined as pathological scoliosis of
unknown etiology that onsets after the age of 10. Mild deformity (curves measuring 10-20°)
affects males and females at similar frequencies [9]. Spinal curvature measuring >20° is less
common, with the most severe curves being the least frequent (Figure 1.3). There is a female
bias in AIS patients with severe curves. In patients with curves measuring >40°, the females-tomale ratio is 10:1 [9]. Anthropometric studies have attempted to characterize other physical
observations in children with AIS. Such studies have noted reduced body mass index in both
female and male AIS patients [10,11]. AIS children are also typically taller than normal, agematched children, which is enhanced when lost height due to curvature is also factored into
measurements [12,13].
In most cases, AIS causes only mild deformity that rarely worsens after skeletal maturity
[14]. Therefore, mild scoliosis is not typically treated. AIS causing moderate (20-40°) and
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severe (>40°) scoliosis has been associated with impaired lung function, resulting in reduced
forced expiratory volume and forced vital capacity [15-17]. Severe scoliosis can also lead to
spinal stenosis with radiculopathy, functional limitations, back pain and cause a deformed
appearance that can be psychologically damaging [18-22]. Moreover, AIS measuring >30°
continues to worsen after skeletal maturity, at an average of 1° per year [14]. Therefore,
treatment is often necessary to improve quality of life and reduce the risk of negative physical
and psychological outcomes in AIS patients with moderate and severe deformity.
Bracing is a nonoperative form of treatment that is considered once curves reach 20-25°.
There are many types of braces available to treat scoliosis (reviewed in [23]), but all braces are
designed to align the spine using external force with the goal of limiting progression and
correcting existing scoliosis.

Compared to other types of scoliosis (e.g. congenital,

neuromuscular), AIS patients are the most likely to benefit from bracing [23], which has been
shown to effectively limit curve progression in some AIS patients [24].
When nonoperative treatments fail, surgery is considered, typically once curves exceed
40-45°. Surgical correction of scoliosis is most frequently achieved through the placement of
instrumentation and spinal fusion (Figure 1.4) (reviewed in [25,26]). More than 18,000 children
undergo major spinal surgery annually because of severe scoliosis [27]. While surgery is an
effective way to correct AIS and prevent further progression of the deformity, there is a risk of
complications. In a study of 702 patients who had surgical correction of AIS, non-neurologic
complications (e.g. infection, excessive bleeding) occurred in 15.4% of patients [28]. In a
separate study, 1,301 AIS patients who underwent spinal surgery were assessed for neurological
complications (e.g. spinal cord injury), which occurred in 0.69% of AIS patients [29]. Because
surgical correction of AIS is invasive and could potentially lead to complications, bracing is
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often prescribed in patients at risk for progression to prevent the need for surgery. Overall, about
10% of AIS patients develop a deformity resulting in bracing or surgery [30]. Risk factors for
progressive AIS include skeletal immaturity, female gender and larger spinal curvature at initial
diagnosis [31].

Genetics of AIS
The pathogenesis of AIS is poorly understood. Many diverse models for the etiology of
AIS have been proposed, including defects in melatonin signaling, asymmetric development of
the spine coupled with biomechanical factors, low bone mass, abnormal estrogen levels,
shortened spinal cord, muscle imbalances and many others (reviewed in [32-35]). Among these
models, no single concept is preferred as the direct cause of AIS. Instead, AIS is considered a
multifactorial disorder that could arise from multiple etiologies.
Though the pathogenesis of AIS is disputed, it is well accepted that AIS has a genetic
basis. It has been recognized since the late 19th century that spinal curvatures tend to run in
families [36]. At least 26% of AIS patients have one or more affected relatives [37], with 6-11%
of first-degree relatives affected [37,38], which exceeds what would be predicted based on AIS
frequencies in the general population. Additionally, monozygotic twins demonstrate higher
concordance for AIS (73%) compared to dizygotic twins (36%) [39]. Curve severity is also
significantly correlated in monozygotic twins [39].
Dominant autosomal and dominant X-linked inheritance has been described [32,40-42],
but most AIS families demonstrate complex, non-Mendelian inheritance. Emerging views of
AIS heritably favor a complex genetic model with large genetic heterogeneity [32,43-46]. With
substantial variation in curve magnitude, rates of progression, age of onset and morphology of
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the deformity among AIS patients, it is also possible that some of these factors arise from
different genetic factors. For example, Cheng et al. [47] proposed a two-step model for the
development of progressive deformity. In the model, predisposition genes contribute to the
overall susceptibility to AIS, while different disease modifier genes contributing to the risk of
progressive scoliosis (Figure 1.5). Though additional studies are needed to support this two-step
model, it demonstrates the potential complexity underlying the genetics of AIS.

AIS linkage studies
Numerous family-based linkage associations have been reported in AIS (reviewed in
[48]). Parametric studies of large, single or multi-families have identified several loci that were
significantly linked to AIS, including 3q12.1 [49], 5q13.3 [49], 9q31.2-q34.2 [50], 12p [51],
17p11.22 [52], 19p13.3 [53] and Xq22.3-q27.2 [42]. Nonparametric studies have identified
significant linkage regions at 6q15-q21 [54] and 10q23-q25.3 [54]. The genes within these loci
relevant to AIS susceptibility have not been determined.
Miller et al. [55] completed a genome-wide screen with 1,198 individuals in 202 AIS
families that had two or more affected individuals. In the study, 391 microsatellite markers
spaced on average 9 cM apart were genotyped to assess linkage in each family. Analysis of all
families under multiple models generated varying linkage results depending on the assumptions
made (model independent vs. autosomal dominance, AIS as a quantitative vs. qualitative trait,
varying severity thresholds). The overall findings indicated four major candidate regions on
chromosome 6, 9, 16 and 17. It was also noted that a subset of families with more severe curves
showed evidence of linkage to chromosome 19, though this locus was less significant when all
families were included in the analysis [55]. This subgroup was later studied in greater detail and
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verified to overlap with the 19p13 region identified by Chan et al. [53], containing several
candidate genes such as fibrillin-3 and thromboxane A2 receptor [56]. Similarly, chromosome
9q31-q34 was first identified by Miller et al. [55] and identified independently in a linkage study
of a five generational family with eight affected individuals [50].
Wise et al. [57] identified linkage from a single Caucasian family on chromosome 18q
with a multipoint nonparametric LOD score of 8.26. Gurnett et al. [58] performed linkage
analysis on a five-generational Caucasian family with AIS affecting thirteen females and
identified a novel chromosome 18q12.1-q12.2 locus with a parametric LOD score of 3.31, which
was encompassed by the region from Wise et al. [56]. Pectus excavatum, a deformity causing
abnormal growth of the ribs and sternum, was also present in one additional female and three
male family members. Interestingly, scoliosis and pectus excavatum are often associated [59].
When family members with pectus excavatum were included in the analysis by Gurnett et al.
[58] as affected, the LOD score increased to 3.86. Approximately 45 genes were predicted
within the linkage region, but no coding mutations were identified in 21 genes that were
resequenced.
While some progress has been made using linkage analysis, successful linkage studies
rely on large families with highly penetrant forms of disease in which individuals are
unambiguously assigned as affected or unaffected. For diseases such as AIS, with variable
expressivity and low penetrance, disease status can be difficult to assign in most families. It has
been noted in previous AIS studies that reliable diagnosis can only be made if radiographs are
obtained for all family members, since many mild forms of scoliosis can occur without the
patient’s knowledge [32,57]. Obtaining radiographs from many individuals in large AIS families
can be challenging; therefore, the usefulness of linkage analysis is limited in many AIS cohorts.
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AIS candidate genes
Further efforts to understand the genetic basis of AIS have focused on candidate gene
studies. Most of these studies have yielded mixed results, with both positive and negative
findings (reviewed in [48]). Matrilin-1 (MATN1) was selected as a candidate for AIS bases on a
scoliosis-like phenotype observed in MATN1 mutant mice [60]. MATN1 is an extracellular
matrix protein that is primarily expressed in cartilage [61].

A microsatellite in the 3’

untranslated region (UTR) of MATN1 was over-transmitted from parents to affected probands in
50 parent-child trios [62].

An association with MATN1 was similarly found in a Chinese

population [60]; however, no association was identified in a large Japanese population
containing 789 AIS cases and 1,239 controls [63].
Genes involved in melatonin signaling have also been a focus of candidate gene studies
based on findings in animal models (see section below). Nearly all studies of the melatonin
receptors 1A (MTNR1A) and 1B (MTNR1B) yielded no association with AIS [63-68], with only
one study reporting a positive association for MTNR1B [69].
Because AIS develops during puberty and has a female bias, both forms of the estrogen
receptors (ESR1 and ESR2) have been implicated as candidate genes. Polymorphic sites in ESR1
(encoding ERα) were associated with progression of AIS >5° from initial evaluation and larger
curves in 304 Japanese females [70]. These results were similarly found in a study of 202
Chinese AIS patients [71] and 67 Chinese AIS patients with spinal curves measuring ≥30° [72],
but no association was identified in a study of 540 Chinese AIS patients with curves ≥20° [73].
ESR2 (encoding ERβ) was associated with AIS susceptibility in 218 patients [74]. However, a
replication study involving 798 AIS patients and 637 controls of Japanese ancestry found no
association with polymorphic sites in either ESR1 or ESR2 [75].
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Gao et al. [76] used linkage analysis from 53 families to identify the chromodomain
helicase DNA-binding protein 7 gene (CDH7) as a candidate for AIS. Nonsense, missense and
splice-site mutations in CDH7 cause CHARGE syndrome (coloboma of the eye, heart defects,
atresia of the choanae, retardation of growth and/or development, genital and/or urinary
abnormalities, and ear abnormalities and deafness) [77]. CHARGE syndrome is also associated
with high rates of scoliosis, which occurs in >60% of CHARGE adolescent and adult patients
[76,78]; thus, the authors hypothesized that milder mutations could contribute to isolated
scoliosis in AIS patients. Sequencing CDH7 in 25 affected patients with AIS did not reveal any
rare single nucleotide polymorphisms (SNPs) that segregated with disease, although a common
polymorphism (rs4738824) was shown to have significant overtransmission of the minor allele
compared to controls [76].

FBN1 and FBN2 as candidate genes for AIS
Like CDH7 and CHARGE syndrome, other genes causing Mendelian disorders with
syndromic forms of scoliosis have been considered as candidates for AIS. Hadley-Miller et al.
[79] hypothesized that the elastic fiber system of the extracellular matrix may could be a possible
etiology of AIS, particularly when there are defects in fibrillin. Fibrillin-1 (FBN1) and fibrillin-2
(FBN2) are glycoproteins that are the major components of 10nm microfibrils and provide
structural support to the extracellular matrix [80,81].

Mutations in FBN1 cause Marfan

syndrome [82], a rare, autosomal dominant disorders that cause scoliosis in 63% of patients [8].
Marfan syndrome is estimated to occur in 1:5,000-1:10,000 individuals. Aortic dilation is the
hallmark feature of Marfan syndrome and predisposes individuals to life-threatening aortic
aneurysms and dissections [83]. Additional features occur in Marfan syndrome with large
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phenotypic variability and include ectopia lentis, tall stature, pectus excavatum and carinatum,
dolichostenomelia, arachnodactyly and joint hypermobility.
Mutations in FBN2 cause congenital contractural arachnodactyly (also called Beals
syndrome) [84], an autosomal dominant disorder that causes scoliosis in 50% of patients [85].
Congenital contractural arachnodactyly is also rare (<1:10,000) and has phenotypic overlap with
Marfan syndrome [86]. Many patients with congenital contractural arachnodactyly are described
as having a Marfanoid appearance, with features such as pectus excavatum and carinatum, tall
stature, dolichostenomelia and arachnodactyly. Distinctive features of congenital contractural
arachnodactyly include “crumpled” ears, muscular hypoplasia and contractures of the major
joints. Although congenital contractural arachnodactyly does not appear to be associated with
the same risk of life-threatening cardiovascular complications as Marfan syndrome, aortic
dilation has been described in several patients and echocardiographic evaluations are currently
recommended [87].
FBN1 and FBN2 are large, complex genes that each consists of approximately 11kb of
coding sequence spread over 65 exons. In Marfan syndrome, over 1,000 mutations have been
described throughout FBN1 [88], with about two-thirds being missense mutations [89]. Most
pathogenic FBN1 mutations are unique to a family [90] and about 20% are de novo [91].
Overall, there is little genotype-phenotype correlation within or between families, with the
exception of the neonatal region of FBN1 (exons 24-32) that is typically associated with a more
severe, early-onset form of Marfan syndrome [89,92]. The neonatal region is also conserved in
FBN2 (exons 23-34) and mutations causing congenital contractural arachnodactyly are limited to
this region [87].

Overall, mutations causing congenital contractural arachnodactyly are
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considerably less common than those causing Marfan syndrome, with only about 40 FBN2
mutations having been described [87,93-95].
Although Marfan syndrome and congenital contractural arachnodactyly are considered to
be highly penetrant, autosomal dominant disorders, FBN1 mutations have been described in
families with isolated kyphoscoliosis [96] and isolated skeletal features including scoliosis [97].
This suggests that fibrillin could play a role in isolated scoliosis. Hadley-Miller et al. [79]
investigated FBN1 with histological specimens collected from AIS patients during surgery.
Immunohistochemical staining of FBN1 from ligamentum flavum showed disorganized and/or
reduced staining in 82% (N=18/22) of AIS patients compared to controls, which occurred
independent of the site of biopsy (e.g. concave, convex, apical of the curve) (Figure 1.6).
Similarly, cultured fibroblasts from AIS patients showed that 17% (N=4/23) of specimens
secreted fibrillin that failed to incorporate into the extracellular matrix. Linkage analysis from
eleven pedigrees containing 96 individuals did not support segregation of the FBN1 locus with
AIS, although segregation within a single family could not be ruled out [98]. Because of the
prohibitively high cost of sequencing these large genes, no further genetic studies of FBN1 or
FBN2 have been pursued in patients with AIS.

AIS genome-wide association studies
Genome-wide association studies (GWAS) rely on the ‘common disease, common
variant’ (CDCV) hypothesis, which argues that common variants in the population, typically
with low disease penetrance, are major contributors to common diseases. Several GWAS have
been performed with AIS cohorts to identify common risk loci. Sharma et al. [99] performed a
GWAS on 419 Texas AIS families with 1,122 individuals and identified common genetic
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polymorphisms associated with AIS near the close homologue of L1 (CHL1) gene, although this
locus did not reach genome-wide significance.

CHL1 is involved in axonal guidance and

neuronal migration [100,101] and Sharma et al. [99] hypothesized CHL1 could be a good
candidate for AIS based on evidence that incorrect axonal targeting can cause the autosomal
recessive disorder horizontal gaze palsy with progressive scoliosis. Horizontal gaze palsy with
progressive scoliosis is caused by homozygous or compound heterozygous mutations in a similar
axonal guidance gene, roundabout homolog 3 (ROBO3) [102].

Interestingly, other genes

involved in axonal guidance pathways were also among the top associations, including down
syndrome cell adhesion molecule (DSCAM) and contactin-associated protein-like 2 (CNTNAP2)
[99].
A second GWAS was performed in 1,376 Japanese females with AIS and 11,297 female
controls [103]. Three common SNPs (rs11190870, rs625039, rs11598564) near the ladybird
homeobox 1 (LBX1) gene were highly associated with AIS in this cohort, reaching genome-wide
significance. Further analysis of LBX1 by reverse transcription polymerase chain reaction (RTPCR) showed LBX1 was expressed in human fetal skeletal muscle and spinal cord. Takahashi et
al. [103] hypothesized that LBX1 could lead to scoliosis through abnormal somatosensory
function. The most significant SNP near LBX1 (rs11190870) replicated in independent cohorts
consisting of 300 AIS patients and 788 controls in a southern Chinese population [104] and 949
AIS patients and 976 controls in a Han Chinese population [105]. The association replicated for
all three SNPs in a cohort of 513 AIS patients and 440 healthy controls from a Han Chinese
population [106].

However, only one SNP (rs11598564) was among the top 100 SNPs

associated with AIS in the Sharma et al. [99] study, which contained mostly individuals of
European ancestry, suggesting possible genetic heterogeneity among ancestral backgrounds.
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The Japanese GWAS from Takahashi et al. [103] was extended by Kou et al. [107],
identifying six additional SNPs with suggestive evidence for association with AIS. One of these
SNPs (rs6570507) reached genome-wide significance after association testing was performed in
an independent cohort of AIS cases and controls. This SNP is in the intron of G protein-coupled
receptor 126 (GPR126). GPR126 was expressed in proliferating chondrocytes in mice and the
authors suggest that GPR126 could affect AIS susceptibility through abnormal skeletal growth.

Animal models for AIS
The genetic and molecular basis of AIS has been difficult to identify, which is in part
attributed to the lack of a relevant animal model. Most animal models of AIS have been
primarily limited to experimental forms of scoliosis, where scoliosis is induced by invasive
surgical procedures, immobilization or the use of the systemic agents (reviewed in [108]). One
of the most extensively studied models of experimentally-induced scoliosis is pinealectomy in
chickens. First noted by Thillard [109] in 1959, surgical removal of the pineal gland in the first
few days after chicks hatch caused chickens to develop scoliosis that progressed until sexual
maturity [110].

The cause of scoliosis was hypothesized to be due to altered melatonin

signaling, although later studies showed that chickens with suppressed melatonin secretion by
constant light did not develop scoliosis [111]. Pinealectomy did not cause scoliosis in rats [112],
unless pinealectomized rats were also made bipedal through amputation of the forelimbs [113].
This finding has led to speculations that bipedalism may be an important consideration for
modeling AIS pathogenesis. However, pinealectomy in guppy [114] and salmon [115] induces
scoliosis, indicating that the pinealectomy model of experimentally-induced scoliosis is not
exclusive to bipedalism.

13

Because spinal deformity develops secondary to harsh interventions, animal models with
experimentally-induced forms of scoliosis are unlikely to recapitulate many features of human
AIS. Few animal models with sporadic, naturally occuring scoliosis have been identified. One
long-term study utilized a stock of chickens that were normal at birth but developed a scoliotic
phenotype as they approached sexual maturity [116]. Over 10 years, McCarrey et al. [116]
selected for scoliosis to create inbred scoliotic stocks and found that long-term selection
increased the incidence of scoliosis to 88.5%, but did not affect curve severity. Though the study
provided evidence for a major gene affect, follow-up studies to identify the genes have not been
performed.
More recently, a possible genetic model for scoliosis was identified in the guppy
(Poecilia reticulata). A single male guppy with spinal curvature was isolated from a laboratory
stock and crossed to generate a lineage called curveback [114]. Of curveback fish born with
normal spines, 79% developed curves within 2 weeks. The age of onset, curve magnitude and
progression varied. Severe spinal curvature was observed in a higher percentage of females than
males.

Numerous crossing schemes suggested that the curveback phenotype has complex

inheritance, with a major gene and modifiers, some of which may be sex-linked.

While

curveback may prove to be a useful model for AIS, the genes causing the curveback phenotype
and the potential association to human AIS remain to be elucidated.

Current understanding of AIS
In the past decade, discovery of disease-causing variants was most often achieved
through linkage, candidate gene sequencing and association studies. These same approaches
have been utilized in the pursuit of genetic variants associated with AIS. Through linkage
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studies, several loci associated with AIS have been successfully identified. However, these
regions have been large, containing many genes and the specific gene(s) relevant to AIS within
these loci remain unknown. Candidate gene studies have yielded mixed findings, with most gene
associations failing to replicate in other AIS cohorts. While this may be the result of large
genetic heterogeneity between ancestral populations or endophenotypes unaccounted for in
replication cohorts, many studies evaluating AIS candidate genes have used case-control designs
with small sample sizes. Thus, additional studies involving larger cohorts of patients are needed
to resolve previous findings. GWAS has successfully identified common variants in LBX1
associated with AIS in a large Japanese cohort [103], which replicated in independent AIS
cohorts from other Asian ancestries [104-106]. However, it is unclear if LBX1 is associated with
AIS in other ancestral populations. Furthermore, common polymorphisms account for only a
small amount of AIS heritability, suggesting that other forms of genetic variation are likely at
play and may have a larger role in AIS susceptibility. Though progress has been made, overall,
the genetic basis of AIS remains poorly understood. As an added challenge, few animal models
have been described and it is currently unclear which species are appropriate to model genetic
findings in human.

Dissertation objectives
The objective of the research presented here is to identify additional genetic risk factors
for AIS, especially rare genetic variants that have not been adequately evaluated as a potential
cause of disease. Our study design will address the ‘common disease, rare variant’ (CDRV)
hypothesis, which states that common diseases are likely due to rare variants of higher
penetrance [117]. First, we will evaluate rare genomic copy number variants in a cohort of AIS
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cases. Rare copy number variation is an established cause of human disease, yet genomic
deletions, duplications and chromosomal aneuploidy have never been explored as a potential risk
factor for AIS. Second, we will utilize the recent advances in next generation sequencing
technology and DNA enrichment to evaluate rare disease-causing sequence variants (single base
mutations and small insertion/deletions) on a genome-wide scale.
The second major objective of this dissertation is to evaluate zebrafish as a potential
animal model for AIS using an ENU-forward genetic screen. Naturally occurring scoliosis has
been demonstrated in the guppy; therefore we hypothesize that the zebrafish, a highly tractable
animal model with diverse molecular and genetic resources, is an ideal model to identify new
mutant strains that could illuminate new candidate genes and molecular pathways that also play a
role in human AIS.
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Figure 1.1: Scoliosis spinal deformity
Graphic showing the appearance of normal spine (left) and a spine with scoliosis (right). Figure
reproduced from [118].
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Figure 1.2: Schematic demonstrating the Cobb method of measuring spinal curvature in
scoliosis
To quantify the magnitude of scoliosis deformity, spinal curvature is measured from frontal
plane using a standing radiograph. The curve, or Cobb angle, is the measured angle created
when lines are drawn parallel to the most tilted vertebrae. Figure reproduced from [27].
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Figure 1.3: Prevalence of AIS by severity
AIS affect 2-3% of the population, but the prevalence decreases with increasing severity. Figure
reproduced from [27].
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Figure 1.4: Preoperative and postoperative radiograph of an AIS patient
Preoperative radiograph (top) shows a patient with severe scoliosis from the frontal and lateral
view. Postoperatively (bottom), the placement of instrumentation and spinal fusion has corrected
the spinal curvature by 60%. Figure reproduced from [119].
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Figure 1.5: A proposed genetic model for AIS development
A two-step model of genetic and environmental factors contributing to AIS development.
Predisposition genes contribute to the AIS susceptibility whereas disease modifier genes
contribute to the risk of progression to severe AIS. Figure reproduced from [47].
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Figure 1.6: Disorganized and reduced fibrillin staining in AIS
Immunohistochemical staining of FBN1 in an individual not affected with scoliosis (top) and a
patient with AIS (bottom). In the AIS patient, reduced staining and/or disorganization was
observed in 82% of patients. Figure reproduced from [31].
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Table 1.1: Four broad categories of scoliosis
Scoliosis classification

Example(s)

Congenital

Wedge-shaped vertebrae, hemivertebrae

Neuromuscular
Syndromic
Idiopathic

Cerebral palsy, Duchenne muscular dystrophy, arthrogryposis,
spinal muscular atrophy
Marfan syndrome, Ehlers-Danlos syndrome, congenital contractural
arachnodactyly
Adolescent idiopathic scoliosis
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Copy Number Variation in Adolescent Idiopathic Scoliosis
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SUMMARY

Adolescent idiopathic scoliosis (AIS) is a complex genetic disorder that causes spinal
deformity in approximately 3% of the population. Candidate gene, linkage and genome-wide
association studies have sought to identify genetic variation that predisposes individuals to AIS,
but the genetic basis remains unclear. Copy number variants (CNVs) are associated with several
isolated skeletal phenotypes, but their role in AIS has never been assessed. In this study, we
determined the frequency of recurrent copy number rearrangements, chromosome aneuploidy
and rare CNVs in AIS patients. We performed genomic copy number analysis on 143 patients
with isolated AIS using the Affymetrix Genome-wide Human SNP Array 6.0. We identified a
duplication of chromosome 1q21.1 in 2.1% (N=3/143) of AIS patients, which was enriched
compared to 0.09% (N=1/1079) of controls (P=0.0057) and 0.07% (N=6/8329) of published
controls (P=0.0004). Other notable findings include trisomy X, which was identified in 1.8%
(N=2/114) of female AIS patients, and rearrangements of chromosome 15q11.2 and 16p11.2 that
may be relevant to scoliosis susceptibility. Finally, we report rare CNVs that will be of use to
future studies investigating candidate genes for AIS.

Overall, our results suggest that

chromosomal microarray may reveal clinically useful abnormalities in some AIS patients.

Portions of this chapter are adapted from: Buchan JG, Alvarado DM, Haller G, Aferol H, Miller
NH, Dobbs MB, Gurnett CA. (2014) “A Role for Copy Number Variation in Adolescent
Idiopathic Scoliosis.” Clinical Orthopedics and Related Research. Accepted manuscript.
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INTRODUCTION

Over the past decade, copy number variation has increasingly been recognized as a major
cause of disease, in what has come to be known as genomic disorders [1]. Genomic disorders
arise when deletions, duplication or inversions affect gene dosage or proximity to regulatory
elements such as enhancers [2]. The mutation rate for copy number variants (CNVs) is estimated
to be two to four magnitudes higher than for point mutations [3].
CNV analysis has been successfully applied to patients with intellectual disability,
neuropsychiatric disorders and multiple congenital abnormalities, revealing multiple genes and
genomic regions contributing to disease susceptibility (reviewed in [4-6]).

In comparison,

relatively few CNV studies have assessed patients with isolated skeletal phenotypes, though
CNVs have been associated with idiopathic short stature [7,8], idiopathic clubfoot [9-11], adultonset degenerative lumbar scoliosis [12] and bone mineral density [13]. Moreover, a recent
study showed that recurrent rearrangements of chromosome 16p11.2 are risk factors for nonidiopathic scoliosis and vertebral abnormalities in children with additional developmental,
neurological and congenital abnormalities [14]. These results demonstrate the potential for
recurrent and other rare CNVs to affected skeletal phenotypes, like scoliosis, and warrants
evaluation of CNVs in patients with AIS.
In this study, we determine the frequency of copy number rearrangements, chromosome
aneuploidy, and rare CNVs from a genome-wide CNV screen of 143 AIS patients and report an
important role for CNVs in AIS pathogenesis.
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METHODS

Patient samples
AIS patients were recruited from the Pediatric Orthopedic Surgery clinics at St. Louis
Children’s Hospital and St. Louis Shriners Hospital for Children. All patients had spinal curves
≥10° as measured with the Cobb method [15] on a standing radiograph. Patients with known or
suspected scoliosis etiologies (e.g. Marfan syndrome, congenital abnormalities) were excluded.
Growth parameters were calculated based on data from the National Center for Health Statistics
(http://www.cdc.gov/nchs/). Blood or saliva samples were collected for probands and available
relatives after obtaining informed consent. DNA isolations were performed using the DNA
Isolation Kit for Mammalian Blood (Roche, Indianapolis, IN, USA) or the Oragene Purifier
(DNA Genotek, Kanata, ON, Canada) according to the manufacturer’s instructions. Replication
cohorts for chromosome 1q21.1 (N=120) and trisomy X (N=172) included AIS patients recruited
from St. Louis Children’s Hospital, St. Louis Shriners Hospital for Children and the University
of Colorado. Human Subjects Committees at all three institutions approved this study.

CNV analysis
Copy number analysis was performed for 148 AIS probands and 1079 controls (666
controls from a bipolar disorder study [16] and 413 idiopathic clubfoot patients [11]) using the
Genome-wide Human SNP Array 6.0 (Affymetrix, Santa Clara, CA, USA). Copy number calls
were generated with the Genotyping Console software (Affymetrix Affymetrix, Santa Clara, CA,
USA) using a reference set of 270 HapMap controls. AIS samples with contrast quality control
(QC) <0.04 and median absolute pairwise difference (MAPD) >0.35 or total CNVs >two
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standard deviations above the average were excluded (N=5). Analysis of the remaining 143 AIS
samples was limited to CNVs ≥125kb in size with ≥50 markers and ≤10kb average distance
between markers. CNVs with >50% overlap with assembly gaps were removed. We identified
rare and novel CNVs by limiting our analysis to CNVs that had <50% overlap with CNVs at
>1% frequency or with all CNVs, respectively, in the Database of Genomic Variants (release
2013-07-23, http://projects.tcag.ca/variation) when ≥100 individuals were evaluated.

To

evaluate known, clinically significant copy number disorders in AIS patients, we identified
CNVs that overlapped genomic regions associated with recurrent copy number disorders,
including 45 recurrent genomic disorder regions (<10 Mb) recently examined in a large control
population [17]. Quantitative PCR (qPCR) using ≥3 PCR primer pairs validated selected CNVs.
All sequence coordinates are reported using NCBI assembly build 36 (hg18).
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RESULTS

To investigate whether CNVs contribute to AIS susceptibility, we evaluated 143
unrelated AIS patients for CNVs with the Affymetrix Genome-wide Human SNP Array 6.0. The
AIS cohort included primarily familial cases with moderate to severe AIS. The average spinal
curve (Cobb angle) for patients in this cohort was 49° and 80% were female (Table 2.1). To
enrich our dataset with high confidence CNVs, our analysis was limited to CNVs ≥125 kb in
size, identified by ≥50 markers with ≤10 kb average distance between markers.

Recurrent copy number rearrangements
Recurrent rearrangements of chromosome 16p11.2 are associated with scoliosis and other
abnormalities [14], but this locus has never been evaluated for CNVs in a patient cohort with
isolated scoliosis and the role of 16p11.2 and other recurrent CNVs in AIS remains unknown.
Therefore, we identified AIS patients with CNVs overlapping 45 loci associated with recurrent
copy number disorders [17]. Seven patients (4.9%, N=7/143) in our AIS cohort had CNVs
overlapping one of the recurrent genomic disorder regions. These CNVs caused rearrangements
of chromosome 1q21.1 (N=3), chromosome 2q13 (N=1), chromosome 15q11.2 (N=2) and
chromosome 16p11.2 (N=1) (Table 2.2).
A duplication of chromosome 1q21.1 was the most frequent finding and was present in
2.1% (N=3/143) of AIS patients compared to 0.09% (N=1/1079) of controls (P=0.0057, onetailed Fisher’s exact test) and 0.07% (N=6/8329) of published controls (P=0.0004, one-tailed
Fisher’s exact test) [17]. After correcting for multiple testing, the enrichment of chromosome
1q21.1 duplications in AIS remained significant compared to published controls (P<0.001).
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Large segmental duplication blocks mediate four recurrent breakpoints in chromosome 1q21.1
CNVs and define distinct proximal and distal regions, but only the proximal region was
duplicated in all three cases (Figure 2.1). To test segregation of the proximal 1q21.1 duplication
with AIS, available family members were evaluated for the presence of the CNV using qPCR.
The proximal 1q21.1 duplication segregated with reduced penetrance in all three pedigrees
(Figure 2.2). AIS ranged in severity from mild to severe in the five affected individuals with the
duplication (Table 2.3). Two carriers of the duplication were unaffected, although this was not
confirmed radiographically. Clinical information and family histories did not reveal evidence for
intellectual or developmental disability or other significant comorbidities in the individuals with
the duplication.
To screen for additional AIS patients with CNVs in chromosome 1q21.1, we used qPCR
to identify proximal 1q21.1 CNVs in an independent replication cohort (N=120), but no
additional chromosome 1q21.1 duplications were identified. However, even combined with the
Affymetrix Genome-wide Human SNP Array 6.0 results, the frequency of proximal 1q21.1
duplications in AIS patients remained enriched compared to controls from this study (N=3/263
vs. N=1/1079, P=0.0255, one-tailed Fisher’s exact test) and published controls (N=3/263 vs.
N=6/8329, P=0.0021, one-tailed Fisher’s exact test) [17].

Trisomy X
We identified large-scale aneuploidy in 1.4% (N=2/143) of AIS patients. Both patients
were female with trisomy of the X chromosome (47, XXX). Trisomy X was therefore present in
1.75% (N=2/114) of female AIS patients and was confirmed by qPCR. Both AIS patients had
tall stature (>99th percentile), but no additional physical or developmental comorbidities, and
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neither had previously been diagnosed with this condition. Only one of 529 females (0.19%) in
our control cohort was identified with trisomy X, similar the 0.11% frequency observed by
Nielsen and Wohlert [18] in a large study of 17,038 newborn females.

We screened an

additional 172 female AIS patients for trisomy X by qPCR and no additional patients were
identified. Thus, the overall frequency of trisomy X in AIS females was 0.7% (N=2/286).

Rare CNVs in AIS patients
To determine if the overall burden of rare CNVs differs between AIS patients and
controls, we identified CNVs that occurred at <1% in the Database of Genomic Variants (<50%
overlap with CNVs present at a frequency of >1% in the Database of Genomic Variants). We
identified 177 rare CNVs in 92 AIS patients (Table 2.4). Of these CNVs, 118 were duplications,
59 were deletions and the average CNV size was 328 kb. The frequency of large (>750 kb),
autosomal CNVs was similar between AIS patients (4.90%, N=7/143) and controls (5.65%,
N=61/1079). A complete list of rare CNVs identified in AIS patients is available in Table 2.5.
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DISCUSSION

Here, we report the first study investigating copy number variation in a cohort of AIS
patients. In this study, 6.3% (N=9/143) of AIS patients were identified with chromosomal
aneuploidy (N=2/143) or a CNV affecting a region previously associated with a recurrent
genomic disorder (N=7/143). Our findings illustrate how frequently clinically relevant CNVs
will be encountered during microarray testing of patients with isolated scoliosis. Because the
current study cohort was ascertained in an orthopedic clinic population and because patients with
obvious developmental and intellectual impairment were excluded from the study, the rate would
likely have been much higher if patients with additional comorbidities were included. While
several of the clinically significant CNVs identified in this study are unlikely to be related to
AIS, others may have a role in AIS pathogenesis or contribute more generally to multiple spinal
phenotypes.
Chromosome 1q21.1 duplications were the most frequently observed chromosomal
abnormality identified in AIS patients. Duplications of 1q21.1 were present in 2.1% of AIS
probands but were found in only 0.07-0.08% of healthy controls [17,19]. Chromosome 1q21.1
spans a complex 5.4 Mb region of which only 25% contains unique, non-duplicated sequence
and approximately 700 kb of sequence is missing due to gaps in the NCBI assembly (build 36)
[20].

Segmental duplications make the region susceptible to recurrent rearrangements by

nonallelic homologous recombination [21]. The most frequently observed breakpoints arise
from four large segmental duplication blocks that define two stretches of unique sequence within
chromosome 1q21.1: the proximal and distal regions located at genomic positions 144 to 144.34
Mb and 145 to 145.9 Mb, respectively. The distal region is associated with many phenotypes,
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including autism [20,22-24], intellectual disability [20,22,25-27], schizophrenia [22,28-33],
microcephaly and macrocephaly [20,22], congenital heart defects [34-36] and abnormalities in
the renal and urinary tract [37]. In contrast, there are far fewer disease associations with the
proximal region. The strongest association is with thrombocytopenia with absent radii (TAR)
syndrome [38], which is frequently caused by compound inheritance of proximal 1q21.1 deletion
and a rare single nucleotide variant in RBM8A [39].

Other phenotypes where proximal

chromosome 1q21.1 duplications and deletions of varying sizes have been noted include
congenital heart defects [40-42], Mayer-Rokitansky-Küster-Hauser syndrome [43], autism [44],
fetal urogenital abnormalities [45] and additional diverse phenotypes [19,46]. Although the three
AIS patients in our cohort had different chromosome 1q21.1 duplication breakpoints, only the
proximal region was common to all three individuals and no individuals reported additional
phenotypes previously associated with chromosome 1q21.1 rearrangements. Duplications of
1q21.1 segregated with AIS in small families with incomplete penetrance, but incomplete
penetrance has also been previously noted in TAR syndrome [38] and other phenotypes [19,47].
Because additional chromosome 1q21.1 duplications were not detected after screening an
additional 120 AIS patient samples, proximal duplications are likely rarer in AIS than estimated
from our original cohort of 143 patients. Nevertheless, the combined dataset of 263 patients still
showed a significant enrichment of proximal 1q21.1 duplications in AIS.
Scoliosis has not been previously described in patients with proximal chromosome
1q21.1 duplications, though the overall number of patients with this genomic abnormality is
relatively small. Scoliosis was not reported in seventeen patients with proximal duplications,
although two patients had other spine phenotypes (lumbar lordosis and lumbosacral
hyperlordosis) [19]. Of thirty-four patients with proximal deletions, three had a spinal phenotype
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(scoliosis, kyphosis and C6-C7 vertebral fusion) [19]. Although previous studies of patients with
proximal chromosome 1q21.1 duplications suggest that scoliosis is not a commonly associated
phenotype, scoliosis is often not detected until adolescence and is therefore likely to be
underreported in younger patient cohorts. Furthermore, mild scoliosis may be underreported in
children with multiple congenital anomalies whose other major medical problems are of greater
concern.

Additional larger studies are needed to determine the importance of

proximal

chromosome 1q21.1 duplications in the etiology of AIS.
Several recurrent CNVs identified in our AIS patient cohort are primarily associated with
cognitive impairment or other related phenotypes, but may also contribute to scoliosis and other
spinal phenotypes. Hemivertebrae were present in 20% (N=2/10) of patients with chromosome
15q11.2 duplications, although none of 15 patients with the reciprocal deletion had vertebral
abnormalities [48].

Two patients in our AIS cohort had chromosome 15q11.2 CNVs.

Chromosome 15q11.2 deletions are strongly associated with developmental delay [17], but the
reciprocal duplication is not and the significance and associated phenotypes of 15q11.2
duplications, if any, are not well established. Neurocognitive or developmental phenotypes were
not present in either of our AIS patients with the 15q11.2 CNVs.
Likewise, a variety of spinal abnormalities, including hemivertebrae, syringomyelia and
scoliosis have been described in patients with rearrangements of chromosome 16p11.2 [14,4954] and this locus was hypothesized to be a risk factor for idiopathic scoliosis [14]. We
identified a chromosome 16p11.2 duplication in one AIS patient with spina bifida occulta. This
patient did not have intellectual or developmental disability, which is consistent with the large
phenotypic variability and reduced penetrance observed in individuals with chromosome
16p11.2 duplications [55].

Interestingly, chromosome 16 was previously associated with
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idiopathic scoliosis by linkage analysis in 202 families [56] and fine-mapping linkage analysis of
544 individuals from an additional 95 families narrowed the association to two regions on
chromosome 16, which included 16p11.2 [57], providing further support for an association of the
16p11.2 locus with AIS.
We identified trisomy of the X chromosome (47, XXX), also called triple X syndrome, in
0.7% (N=2/286) female AIS patients. Triple X syndrome is estimated to occur in 1 of 1,000
female births and generally causes mild phenotypes, such as premature ovarian failure and
learning disabilities, which results in many patients being undiagnosed [58]. Scoliosis is well
known to occur more frequently in triple X syndrome than in the general population [59-61].
Specifically, Olanders (1977) described scoliosis in 15.2% (N=5/33) of patients with triple X
syndrome [61]. Patients with triple X syndrome are also typically taller than average, with the
average height being >80th percentile by the age of fourteen [62]. Both AIS patients with
trisomy X in our series were tall (>99th percentile for height) but reported no additional
phenotypes. Testing for triple X syndrome should be considered in tall females with AIS so that
other associated phenotypes, such as premature ovarian failure and developmental delay, can be
monitored.
There are several limitations to our study, including the relatively small sample size. For
the rare CNVs discussed here, a larger sample size would have improved frequency estimates
and provided more statistical power. Moreover, in many cases additional family members were
unavailable for testing and limited our ability to provide additional support for causality.
Second, controls used in this study included a large number of patients with idiopathic clubfoot
and CNVs have already been associated with this phenotype [9-11]. However, we also reference
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the frequency of recurrent CNVs in an even larger published independent control dataset [17]
and these frequencies are very similar to our control dataset.
In summary, this study reports the first analysis of copy number variation in a large
cohort of patients with AIS. Our data shows that over 6% of AIS patients harbor a clinically
significant copy number abnormality and many of these are likely risk factors for scoliosis and
other spinal phenotypes. Our results suggest that microarray analysis for CNVs may be a useful
clinical test in this patient population. Finally, we provide a list of all rare CNVs identified in
AIS patients, which will be useful for future studies evaluating candidate genes for AIS.
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Figure 2.1: Proximal chromosome 1q21.1 duplications identified in AIS patients
Log2 ratios for three AIS probands identified with CNVs at chromosome 1q21.1 show the
location of the duplications (shaded). The four recurrent breakpoints (BP1-BP4) and
approximate locations of the proximal and distal regions are shown. Image modified from
Genome Browser (http://genome.ucsc.edu). All genomic coordinates are shown for NCBI
assembly build 36 (hg18).
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Figure 2.2: Segregation of chromosome 1q21.1 duplications
Duplications segregated in AIS probands (arrows) and family members with reduced penetrance.
Dup, duplication; -, wild type.
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Table 2.1: Demographics of 143 AIS probands analyzed for
copy number variation
Familial
Non-familial Total
AIS cases
134 (94%)
9 (6%)
143
Male
29 (100%)
0 (0%)
29 (20%)
Female
105 (92%)
9 (8%)
114 (80%)
Cobb angle
Mean
49° (n=122)
50° (n=9)
49° (n=131)
Range
10-97° (n=122) 26-74° (n=9)
10-97° (n=131)
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Table 2.2: Frequency of 45 genomic copy number disorder regions in AIS patients
AIS patients (this study)
Genomic
Size
Abnormality disorder
(kb)
region (Mb)
Patient(s) Phenotype(s) CNV (Mb)

Controls (this study)
Size
(kb)

Controls (published)
[17]

Frequency

Frequency

p-value Frequency

p-value

49

1q21.1
duplication
(proximal)

chr1:
144-144.34

340

6041-001
6267-001
6035-004

AIS
AIS
AIS

chr1:142.72-144.97 2241
chr1:144.08-144.50 420
chr1:144.08-144.46 379

2.10%
(n=3/143)

0.09%
(n=1/1079)

0.0057

0.07%
(n=6/8329)

2q13
duplication

chr2:
160
110.18-110.34

6126-001

AIS

chr2:110.13-110.52 394

0.70%
(n=1/143)

0.65%
(n=7/1079)

0.6316

0.38%
0.4304
(n=32/8329)

15q11.2
deletion

chr15:
20.35-20.64

290

6053-001

AIS

chr15:19.09-21.04 1949

0.70%
(n=1/143)

0.37%
(n=4/1079)

0.4639

0.23%
0.2888
(n=19/8329)

15q11.2
duplication

chr15:
20.35-20.64

290

6036-001

AIS

chr15:20.22-20.97 744

0.70%
(n=1/143)

0.46%
(n=5/1079)

0.5269

0.43%
0.4681
(n=36/8329)

16p11.2
duplication

chr16:
29.56-30.11

550

6032-001

AIS, spina
chr16:29.50-30.09 587
bifida occulta

0.70%
(n=1/143)

0.19%
(n=2/1079)

0.3118

0.02%
(n=2/8329)

Genomic coordinates are reported using NCBI assembly build 36 (hg18)

0.0004

0.0498

Table 2.3: Clinical information for individuals identified with chromosome 1q21.1
duplications
1q21.1
Affected
Family Individual Sex
Curve type
Treatment
status
(Cobb angle)
6035

6041

6267

004*

F

Dup/-

Yes (15°)

NA

None

002
001

F
F

Dup/NA

Yes, mild
Yes (56°)

NA
Right thoracic

None
Surgery

001*

M

Dup/-

Yes (31°)

Right thoracic

Brace

002

F

Dup/-

Yes

NA

Surgery

003

F

Dup/-

No

Not affected

Not affected

001*

M

Dup/-

Yes (44°)

Right thoracic

Surgery

002

F

-/-

No

Not affected

Not affected

003
M
Dup/No
Not affected
Not affected
Abbreviations: NA, not available; F, female; M, male; Dup, duplication; -, wild type
*Proband
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Table 2.4: Summary of rare CNVs (<1% frequency in DGV) identified in AIS patients
AIS patients
143
AIS patients with rare CNVs
92
Total rare CNVs
177
Rare CNVs containing Refseq genes
130
Average CNV size

328 kb

Median CNV size

217 kb

Duplications

118

Deletions

59

Large autosomal CNVs (>750 kb)

7

AIS patients with large CNVs

4.90%

In-house controls with large CNVs

5.65%

Abbreviations: DGV, Database of Genomic Variants; CNV, copy number variant
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Table 2.5: Rare CNVs identified in AIS cases
Patient
ID
6205-001
6278-001
6062-001

Position
(hg18)
chr1:5906162659195775
chr1:102428272102625426
chr1:119724173119956321

CNV

Size
(kb)

# of
marke
rs

Distance
between
markers

Genes (Haploinsufficiency index [63])

Dup

134

105

1

LOC100131060 (NA),

Del

197

152

1

Dup

232

232

1

MIR548AI (NA),
HAO2 (93.7%), HSD3B2 (NA), HSD3B1 (69.0%), HSD3BP4
(NA), LINC00622 (NA),
LOC100288142 (NA), LINC00623 (NA), LOC728875 (NA),
PPIAL4B (NA), PPIAL4C (NA), PPIAL4A (NA), NBPF12
(NA), PFN1P2 (NA), NBPF8 (NA), NBPF9 (NA), LOC653513
(NA), PDE4DIP (NA), SEC22B (NA), NOTCH2NL (NA),
HFE2 (8.3%), TXNIP (46.2%), POLR3GL (66.1%),
ANKRD34A (NA), LIX1L (27.4%), RBM8A (33.3%),
GNRHR2 (NA), PEX11B (35.1%), ITGA10 (21.5%),
ANKRD35 (63.3%), PIAS3 (9.2%), NUDT17 (43.5%),
POLR3C (32.7%), RNF115 (NA), CD160 (88.1%), PDZK1
(39.5%), GPR89A (NA), GPR89C (NA), PDZK1P1 (NA),
LOC728989 (NA),
PPIAL4A (NA), NBPF8 (NA), NBPF9 (NA), HFE2 (8.3%),
TXNIP (46.2%), POLR3GL (66.1%), ANKRD34A (NA),
LIX1L (27.4%), RBM8A (33.3%), GNRHR2 (NA), PEX11B
(35.1%), ITGA10 (21.5%), ANKRD35 (63.3%), PIAS3 (9.2%),
NUDT17 (43.5%), POLR3C (32.7%), RNF115 (NA), CD160
(88.1%), PDZK1 (39.5%),
PPIAL4A (NA), NBPF8 (NA), NBPF9 (NA), HFE2 (8.3%),
TXNIP (46.2%), POLR3GL (66.1%), ANKRD34A (NA),
LIX1L (27.4%), RBM8A (33.3%), GNRHR2 (NA), PEX11B
(35.1%), ITGA10 (21.5%), ANKRD35 (63.3%), PIAS3 (9.2%),
NUDT17 (43.5%), POLR3C (32.7%), RNF115 (NA), CD160
(88.1%), PDZK1 (39.5%), GPR89A (NA),
PPIAL4A (NA), NBPF8 (NA), NBPF9 (NA), RNF115 (NA),
CD160 (88.1%), PDZK1 (39.5%),
PPIAL4A (NA), NBPF8 (NA), NBPF9 (NA), RNF115 (NA),
CD160 (88.1%), PDZK1 (39.5%), GPR89A (NA),
PPIAL4A (NA), NBPF8 (NA), NBPF9 (NA), GPR89C (NA),
PDZK1P1 (NA), ACP6 (82.8%), GJA5 (83.7%), GJA8 (NA),
GPR89B (NA), NBPF11 (NA), NBPF24 (NA), NBPF10 (NA),
MIR5087 (NA), LOC100130000 (NA), FLJ39739 (NA),
PPIAL4D (NA), PPIAL4E (NA), PPIAL4F (NA), NBPF14
(NA), NBPF15 (NA), NBPF16 (NA), LOC645166 (NA),
NBPF23 (NA), LOC388692 (NA),

6041-001

chr1:142724939144965462

Dup

2241

425

5

6035-004

chr1:144083908144463196

Dup

379

162

2

6267-001

chr1:144083908144503409

Dup

420

166

3

Dup

126

53

2

Dup

166

57

3

Dup

1983

400

5

Dup

552

57

10

NBPF15 (NA), NBPF16 (NA), LOC645166 (NA),

Del

462

68

7

NBPF16 (NA), LOC645166 (NA),

Del

490

73

7

NBPF16 (NA), LOC645166 (NA), NBPF23 (NA),

Del

490

73

7

NBPF16 (NA), LOC645166 (NA), NBPF23 (NA),

Del

490

73

7

NBPF16 (NA), LOC645166 (NA), NBPF23 (NA),

Del

528

87

6

NBPF16 (NA), LOC645166 (NA), NBPF23 (NA),

Del

540

89

6

NBPF16 (NA), LOC645166 (NA), NBPF23 (NA),

Del

528

84

6

NBPF16 (NA), LOC645166 (NA), NBPF23 (NA),

Del

402

66

6

NBPF16 (NA), LOC645166 (NA), NBPF23 (NA),

Del

132

60

2

ACBD6 (25.1%),

Del

132

70

2

ZNF670

Dup

164

110

1

TPO (51.9%),

6194-001
6010-001

6041-001

6180-001
6211-001
6221-001
6241-001
6293-001
6193-006
6178-001
6053-001
6322-001
6339-001
6044-001
6068-001

chr1:144337051144463196
chr1:144337051144503409

chr1:145574884147558211

chr1:146797048147349249
chr1:146928878147390822
chr1:146928878147419014
chr1:146928878147419014
chr1:146928878147419014
chr1:146928878147456930
chr1:146928878147469205
chr1:146929009147456930
chr1:147017157147419014
chr1:178525369178657666
chr1:245244567245377000
chr2:13958871559511

52

6240-001
6237-001
6136-004
6028-001
6206-001
6339-001
6157-001
6062-001
6314-001
6157-001
6029-001
6304-001
6306-001
6209-001
6306-001
6303-001
6050-001
6213-001
6050-001
6327-001
6081-001
6306-001
6303-001
6238-001
6163-001
6206-001
6305-001
6233-001
6306-001
6126-001
6194-001
6303-001
6317-001
6206-001

chr2:4938926049514365
chr2:5077420251158243
chr2:5257381952705065
chr2:8702622687302219
chr2:101027972101981034
chr2:184585902184999185
chr2:236540644236695522
chr2:238308001238479991
chr3:537642882120
chr3:2120466221330495
chr3:3578027535916762
chr3:3578027535916762
chr3:5040619850592426
chr3:126907150127103540
chr3:126907150127112518
chr3:126907150127147683
chr3:126929342127103540
chr3:143303623143569349
chr3:143307337143569349
chr3:162898796163031671
chr3:164396601164833278
chr4:38408484256969
chr4:39921594236511
chr4:39921594243961
chr4:40602454254791
chr4:40663444236387
chr4:6905458669475447
chr4:6905458669592854
chr4:6905458669592854
chr4:6905752469475447
chr4:6905752469518358
chr4:6905752469592854
chr4:6905752469592854
chr4:6909635569592854

Del

125

112

1

Del

384

255

2

Dup

131

117

1

Dup

276

53

5

Dup

953

518

2

Del

413

332

1

Dup

155

86

2

AGAP1 (NA),

Del

172

110

2

LRRFIP1 (80.0%), RBM44 (NA), RAMP1 (75.1%),

Dup

344

228

2

Del

126

89

1

Dup

136

79

2

ARPP21 (NA),

Dup

136

79

2

ARPP21 (NA),

Dup

186

86

2

CACNA2D2 (23.2%), C3orf18 (36.2%), HEMK1 (96.6%),

Dup

196

77

3

MIR548I1 (NA),

Dup

205

78

3

MIR548I1 (NA),

Dup

241

86

3

MIR548I1 (NA), FAM86JP (NA), ALG1L (NA),

Dup

174

72

2

MIR548I1 (NA),

Dup

266

118

2

TFDP2 (2.9%), GK5 (77.4%), XRN1 (11.8%),

Dup

262

116

2

TFDP2 (2.9%), GK5 (77.4%), XRN1 (11.8%),

Del

133

98

1

Del

437

197

2

CT64 (NA),

Dup

416

104

4

FAM86EP (NA), OTOP1 (84.7%),

Dup

244

69

4

FAM86EP (NA),

Dup

252

75

3

FAM86EP (NA), OTOP1 (84.7%),

Dup

195

75

3

OTOP1 (84.7%),

Dup

170

56

3

Dup

421

68

6

UGT2B17 (98.0%), UGT2B15 (NA), TMPRSS11E (56.4%),

Dup

538

71

8

UGT2B17 (98.0%), UGT2B15 (NA), TMPRSS11E (56.4%),

Dup

538

71

8

UGT2B17 (98.0%), UGT2B15 (NA), TMPRSS11E (56.4%),

Dup

418

67

6

UGT2B17 (98.0%), UGT2B15 (NA), TMPRSS11E (56.4%),

Dup

461

68

7

UGT2B17 (98.0%), UGT2B15 (NA), TMPRSS11E (56.4%),

Dup

535

70

8

UGT2B17 (98.0%), UGT2B15 (NA), TMPRSS11E (56.4%),

Dup

535

70

8

UGT2B17 (98.0%), UGT2B15 (NA), TMPRSS11E (56.4%),

Dup

496

56

9

UGT2B17 (98.0%), UGT2B15 (NA), TMPRSS11E (56.4%),

NRXN1 (NA),

RGPD2 (NA), RGPD1 (NA), PLGLB1 (NA), PLGLB2 (NA),
LOC285074 (NA), MIR4771
TBC1D8 (64.4%), CNOT11 (NA), SNORD89 (NA), RNF149
(82.4%), MIR5696 (NA), CREG2 (82.4%), RFX8 (NA),
MAP4K4 (21.9%), LOC100506328 (NA), IL1R2 (12.8%),

53

6085-001
6303-001
6217-001
6293-001

6306-001

6219-001
6010-001
6094-001
6259-001
6018-001
6197-001
6187-001
6201-001
6303-001
6238-001
6094-001
6300-001
6171-001
6289-001
6138-001
6086-001
6178-001
6337-001
6125-001
6337-001
6138-001
6040-001
6304-001
6171-001
6128-002
6223-001
6219-001
6211-001

chr4:127358793127503594
chr4:131801982132011871
chr4:135143484135405069
chr4:135190819135405069
chr4:191028537191254119
chr5:9728127897455710
chr5:115241061115450833
chr5:137227123137361288
chr6:13880981633999
chr6:42007444416634
chr6:5743173857781441
chr6:6700522267492828
chr7:43215844501323
chr7:90144639359327
chr7:5759347457736164
chr7:6372663063864919
chr7:6377765563912674
chr7:100753806100924034
chr7:123003085123170697
chr7:128220854128399562
chr7:142001612142135250
chr8:1110195611360722
chr8:3974033541221920
chr8:5355236753895567
chr8:5357191854677369
chr8:5358377953968156
chr9:2817682128337679
chr9:8959278789744027
chr9:119155660120345735
chr10:3521042135356001
chr10:6772403167879925
chr10:6803766868211255
chr10:8177596581962789

Del

145

100

1

Dup

210

120

2

Del

262

126

2

PABPC4L (NA),

Del

214

98

2

PABPC4L (NA),

Dup

226

58

4

FRG1 (NA), LOC283788 (NA), FRG2 (NA), LOC100288255
(NA), DUX4L2 (NA), DUX4L3 (NA), DUX4L4 (NA),
DUX4L5 (NA), DUX4L6 (NA), DUX2 (NA), DUX4L7 (NA),
LOC100653046 (NA),

Del

174

91

2

Dup

210

174

1

AP3S1 (NA), AQPEP (NA), ARL14EPL (NA), COMMD10
(46.9%),

Dup

134

59

2

MYOT (18.2%), PKD2L2 (33.4%), FAM13B (NA),

Dup

246

208

1

FOXC1 (9.7%), GMDS (54.4%),

Del

216

213

1

Dup

350

157

2

Del

488

387

1

Del

180

171

1

Dup

345

296

1

Dup

143

56

3

Dup

138

70

2

ZNF107 (NA),

Del

135

56

2

ZNF107 (NA), ZNF138 (NA),

Dup

170

74

2

COL26A1 (NA),

Dup

168

100

2

ASB15 (75.4%), LMOD2 (NA), WASL (4.2%),

PRIM2 (4.1%),

Dup

179

71

3

CCDC136 (79.2%), FLNC (34.3%), ATP6V1F (NA),
LOC100130705 (NA), KCP (NA), IRF5 (73.9%), TNPO3
(15.8%),

Del

134

89

2

MTRNR2L6 (NA),

Dup

259

214

1

Dup

1482

1129

1

Dup

343

201

2

FAM150A (NA), RB1CC1 (9.0%),

Dup

1105

745

1

FAM150A (NA), RB1CC1 (9.0%), NPBWR1 (78.3%), OPRK1
(69.1%),

Dup

384

223

2

FAM150A (NA), RB1CC1 (9.0%),

Del

161

135

1

LINGO2 (4.3%),

MTMR9 (82.9%), SLC35G5 (NA), TDH (NA), C8orf12 (NA),
FAM167A (NA),
ADAM2 (53.0%), IDO1 (NA), IDO2 (NA), C8orf4 (43.8%),
ZMAT4 (22.1%),

Dup

151

94

2

CTSLP8 (NA), LOC392364 (NA), SPATA31E1 (NA),
SPATA31C1 (NA),

Dup

1190

920

1

ASTN2 (NA), TLR4 (49.1%),

Dup

146

85

2

CUL2 (10.0%),

Del

156

95

2

CTNNA3 (62.1%),

Del

174

142

1

CTNNA3 (62.1%),

Dup

187

124

2

TMEM254

54

6044-001
6233-001
6053-001
6341-001
6026-001
6330-001
6085-001
6303-001
6306-001
6206-001
6275-001
6038-001
6157-001
6316-002
6277-001
6121-001
6205-001
6303-001
6317-001
6180-001
6337-001
6206-001
6306-001
6073-001
6330-001
6121-001
6171-001
6036-001
6085-001
6086-001
6044-001
6216-001
6234-001
6033-001
6035-004

chr10:9365895893822581
chr10:10708990
0-107306982
chr10:10709213
2-107306982
chr10:12836147
9-128559804
chr11:50239345170989
chr11:4960143749808604
chr11:5544237555582755
chr11:7102977571201199
chr11:7102977571205347
chr11:7102977571214508
chr12:7151764671654142
chr12:8941957189655818
chr12:9853995998709344
chr12:11275241
6-113046826
chr12:13053353
5-130710089
chr13:1794362818217635
chr13:1794362818267580
chr13:1813867618316876
chr13:1818485618310275
chr13:1905440319380872
chr13:3388779534035511
chr13:5401668454374043
chr13:7524190175394225
chr14:2152412722030660
chr14:2155535221950283
chr14:2157514822029666
chr14:2165600221786451
chr14:2165600222008051
chr14:2166071722020331
chr14:2166428622017122
chr14:2166899921801251
chr14:2169732621950283
chr14:2169732622020331
chr14:2171150521964093
chr14:2172125421970760

Dup

164

76

2

FGFBP3 (NA), BTAF1 (2.3%), CPEB3 (9.7%),

Dup

217

125

2

Dup

215

124

2

Del

198

170

1

Del

147

127

1

OR52J3 (NA), OR52E2 (NA), OR52A5 (NA), OR52A1 (NA),

Dup

207

112

2

LOC440040 (NA),

Del

140

106

1

OR5I1 (95.5%), OR10AG1 (NA), OR7E5P (NA), OR5F1 (NA),
OR5AS1 (NA),

Dup

171

51

3

FAM86C1 (NA), ALG1L9P (NA),

Dup

176

53

3

FAM86C1 (NA), ALG1L9P (NA), ZNF705E (NA),

Dup

185

56

3

FAM86C1 (NA), ALG1L9P (NA), ZNF705E (NA),

Del

136

89

2

Del

236

129

2

Del

169

97

2

ANKS1B (51.7%), FAM71C (95.3%),

Dup

294

290

1

RBM19 (42.2%),

Dup

177

181

1

Dup

274

60

5

LINC00417 (NA),

Del

324

70

5

LINC00417 (NA),

Dup

178

77

2

LINC00417 (NA), ANKRD20A9P (NA),

Dup

125

59

2

LINC00417 (NA), ANKRD20A9P (NA),

Dup

326

152

2

MPHOSPH8 (75.4%), PSPC1 (65.3%), ZMYM5 (93.2%),

Dup

148

107

1

LINC00457 (NA),

Del

357

211

2

Dup

152

157

1

Del

507

438

1

Del

395

344

1

Del

455

389

1

Del

130

135

1

Del

352

296

1

Del

360

312

1

Del

353

305

1

Del

132

141

1

Del

253

215

1

Del

323

266

1

Del

253

204

1

Del

250

198

1

LMO7 (89.7%), C13orf45 (NA),

55

6012-001
6337-001
6041-001
6073-001
6179-001
6068-001
6234-001
6271-003
6218-001
6317-001
6077-001
6306-001
6106-001
6298-001
6238-001
6028-001
6322-001
6221-001
6233-001
6126-001
6305-001
6032-001
6306-001
6301-001
6073-001
6271-003
6306-001
6161-001
6269-001
6038-001
6123-001
6306-001
6300-001

chr14:2172125422008051
chr14:2181758821950283
chr14:4202798342411046
chr14:6041197160589931
chr14:99592280100113598
chr15:3175394232244695
chr15:4393491344070720
chr16:49710835288139
chr16:60820246284589
chr16:1467812115034391
chr16:1468488215002197
chr16:1468488215002197
chr16:1479608414984969
chr16:1479608414994666
chr16:1480368614987944
chr16:1480368614994666
chr16:1484682914987944
chr16:1484682915002197
chr16:1484682915002197
chr16:1488846615023746
chr16:1654086217012694
chr16:2949882930085908
chr16:3464547234832848
chr16:7392638674080901
chr17:692289837961
chr17:1581122316033881
chr17:2016634320584318
chr17:2128189321476920
chr17:2128189321495308
chr17:2898126429962135
chr17:5145547151672518
chr18:1410391614341363
chr18:1413947114388602

Del

287

218

1

Del

133

87

2

Dup

383

244

2

Del

178

82

2

Dup

521

246

2

Dup

491

389

1

Del

136

107

1

Del

317

188

2

Dup

203

229

1

Dup

356

82

4

Dup

317

75

4

Dup

317

75

4

Dup

189

52

4

ABCC6P2 (NA), NOMO1 (NA), MIR3179

Dup

199

64

3

ABCC6P2 (NA), NOMO1 (NA), MIR3179

Dup

184

55

3

ABCC6P2 (NA), NOMO1 (NA), MIR3179

Dup

191

63

3

ABCC6P2 (NA), NOMO1 (NA), MIR3179

Dup

141

52

3

NOMO1 (NA), MIR3179

Dup

155

66

2

NOMO1 (NA), MIR3179

Dup

155

66

2

NOMO1 (NA), MIR3179

Del

135

64

2

NOMO1 (NA), MIR3179

Dup

472

198

2

Dup

587

198

3

Dup

187

52

4

Del

155

75

2

CFDP1 (13.2%), TMEM170A (NA), CHST6 (70.7%),

Dup

146

82

2

NXN (37.4%),

Dup

223

106

2

Dup

418

83

5

Dup

195

87

2

Dup

213

94

2

C17orf51 (NA),

MNAT1 (3.1%), TRMT5 (NA), SLC38A6 (95.6%),
EVL (7.5%), MIR342 (NA), DEGS2 (NA), YY1 (4.4%),
SLC25A29 (NA), MIR345 (NA), SLC25A47 (NA), WARS
(48.9%), WDR25 (58.5%), BEGAIN (NA),
RYR3 (37.6%), AVEN (90.0%), CHRM5 (44.2%), EMC7
(NA), PGBD4 (NA), KATNBL1 (NA),

SEC14L5 (NA), NAGPA (85.5%),

PLA2G10 (71.6%), NPIPA2 (NA), NPIPA3 (NA), ABCC6P2
(NA), NOMO1 (NA), MIR3179
PLA2G10 (71.6%), NPIPA2 (NA), NPIPA3 (NA), ABCC6P2
(NA), NOMO1 (NA), MIR3179
PLA2G10 (71.6%), NPIPA2 (NA), NPIPA3 (NA), ABCC6P2
(NA), NOMO1 (NA), MIR3179

SLC7A5P1 (NA), SPN (NA), QPRT (NA), C16orf54 (NA),
ZG16 (NA), KIF22 (NA), MAZ (32.2%), PRRT2 (41.6%),
PAGR1 (NA), MVP (69.2%), CDIPT (69.0%), CDIPT

ADORA2B (87.8%), ZSWIM7 (NA), TTC19 (50.4%), NCOR1
(16.5%),
CCDC144CP (NA), LGALS9B (NA), KRT16P3 (NA),
CDRT15L2 (NA), LOC100287072 (NA),
C17orf51 (NA),

Dup

981

937

1

ASIC2 (NA), CCL2 (26.0%), CCL7 (95.8%), CCL11 (99.6%),
CCL8 (96.3%), CCL13 (99.2%), CCL1 (99.9%), C17orf102
(NA), TMEM132E (33.5%),

Dup

217

221

1

ANKFN1 (27.1%),

Dup

237

52

5

ZNF519 (NA), ANKRD20A5P (NA), CYP4F35P (NA),

Dup

249

60

4

ANKRD20A5P (NA), CYP4F35P (NA),

56

6033-001
6306-001
6341-001
6218-001
6028-001
6036-001
6233-001
6316-002
6233-001
6202-001
6280-001
6094-001
6209-001
6026-001
6278-001
6031-001
6274-001
6328-001
6077-001
6098-001
6306-001

chr18:6026093860420239
chr19:1243534512561674
chr21:3464660934823160
chrX:29657783158320
chrX:64651518093257
chrX:72279697412657
chrX:73739457782233
chrX:77999768094650
chrX:78122458092678
chrX:94081229997284
chrX:5674891558490459
chrX:5738644357517736
chrX:5829889158497269
chrX:6164554262073324
chrX:6164554262112687
chrX:6561630266104307
chrX:6567829465850037
chrX:8960942689831490
chrX:9227379492723465
chrY:1460828714807693
chrY:2588973626066330

Dup

159

92

2

Del

126

54

2

ZNF709 (NA), ZNF564 (NA), ZNF490 (54.9%),

Dup

177

102

2

KCNE2 (89.8%), SMIM11 (NA), KCNE1 (76.7%), RCAN1
(NA),

Dup

193

181

1

ARSF (76.4%),

Dup

1628

1213

1

HDHD1 (NA), MIR4767 (NA), STS (45.2%), VCX (NA),
PNPLA4 (64.3%), MIR651 (NA),

Dup

185

135

1

STS (45.2%),

Dup

408

308

1

VCX (NA),

Dup

295

245

1

PNPLA4 (64.3%), MIR651 (NA),

Dup

280

231

1

PNPLA4 (64.3%), MIR651 (NA),

Dup

589

505

1

Del

1742

806

2

Dup

131

68

2

Dup

198

56

4

Dup

428

68

6

Dup

467

82

6

Dup

488

241

2

EDA2R (NA),

Dup

172

88

2

EDA2R (NA),

Dup

222

60

4

Dup

450

285

2

Dup

199

120

2

VCY (NA),

Dup

177

58

3

GOLGA2P2Y (NA), GOLGA2P3Y (NA), CSPG4P1Y (NA),

TBL1X (NA), GPR143 (79.8%), SHROOM2 (70.2%),
LOC100288814 (NA), WWC3 (NA),
LOC550643 (NA), UQCRBP1 (NA), SPIN3 (NA), SPIN2B
(43.4%), SPIN2A (NA), FAAH2 (62.4%), ZXDB (NA), ZXDA
(NA),
FAAH2 (62.4%),

Abbreviations: Dup, duplication; Del, deletion; CNV, copy number variant; ID, identifier
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Chapter 3:
Exome Sequencing Identifies Rare Variants in FBN1 and FBN2 Associated
with Severe Adolescent Idiopathic Scoliosis
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SUMMARY

Despite a strong genetic basis, few genes have been associated with AIS and the
pathogenesis remains poorly understood. In a genome-wide rare variant burden analysis using
exome sequence data, we identified FBN1 (fibrillin-1) as the most significantly associated gene
with AIS. Based on these results, FBN1 and a related gene, FBN2 (fibrillin-2), were sequenced
in a total of 852 AIS cases and 669 controls. In individuals of European ancestry, rare variants in
FBN1 and FBN2 were enriched in severely affected AIS cases (7.6%) compared to in-house
controls (2.4%) (OR=3.5, P=5.46×10-4) and Exome Sequencing Project controls (2.3%)
(OR=3.5, P=1.48×10-6). Scoliosis severity in AIS cases was associated with FBN1 and FBN2
rare variants (P=0.0012) and replicated in an independent Han Chinese cohort (P=0.0376),
suggesting that rare variants have utility as predictors of curve progression. Clinical evaluations
revealed that the majority of AIS cases with rare FBN1 variants do not meet diagnostic criteria
for Marfan syndrome, though variants are associated with tall stature (P=0.0035) and
upregulation of the TGF-β pathway. Overall, these results expand our definition of fibrillinrelated disorders to include AIS and open up new strategies for diagnosing and treating severe
AIS.
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INTRODUCTION

The human exome consists of about 180,000 exons spread across ~38 megabases (Mb).
Although this represents only 1% of the genome, disrupted protein-coding regions make up
about 85% of known variation underlying Mendelian disorders [1].

Therefore, exome

sequencing provides an unbiased, genome-wide approach to identify variation in the regions that
are most likely to have large affects.
Rare variants are thought to have a greater contribution to disease risk because negative
selection restricts variants of large genetic effect from rising to high frequency [2]. We therefore
hypothesized that rare genetic variants are a major contributor to severe AIS susceptibility.
Although large-scale sequencing studies are needed to detect rare variants, such studies have
recently become feasible due to emerging sequencing technologies and reduction in sequencing
cost. Using exome sequencing, we first analyzed rare variants genome-wide in a small cohort of
severe AIS cases and identified FBN1 and FBN2 as candidate genes for AIS, which we then
sequenced in a larger case and control cohort using a newly described, cost-effective targeted
capture method.
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METHODS

Patient samples and controls
AIS patients were recruited from St. Louis Children’s Hospital, St. Louis Shriners
Hospital for Children, the University of Iowa, the University of Colorado and the Chinese
University of Hong Kong. All patients had scoliosis of unknown etiology with spinal curves
measuring ≥10°. Curve measurements are reported for the largest lateral spinal curve using the
Cobb method [3]. Patients with developmental delay, multiple congenital anomalies or known
underlying medical disorders (e.g. Ehlers-Danlos syndrome, Marfan syndrome) were excluded.
We selected 91 unrelated AIS cases of European ancestry with severe deformity (spinal curves
measuring ≥40° or requiring surgery) for the exome sequencing screen. Additional AIS cases of
European (N=344), Han Chinese (N=370) and other ancestries (N=47) were included in
subsequent analyses.

DNA was collected from affected probands after obtaining informed

consent. Growth parameters were calculated using the National Center for Health Statistics
(http://www.cdc.gov/nchs). Systemic features of Marfan syndrome and joint hypermobility were
quantified according to the revised Ghent scoring system [4], and the Beighton scoring system
[5], respectively, and were obtained in patients without knowledge of genetic sequencing results.
A subset of AIS cases were recontacted after FBN1 variants previously identified in individuals
with Marfan syndrome or novel variants of uncertain significance were identified as a part of this
research study. These cases were referred to clinical geneticists at St. Louis Children’s Hospital
and St. Louis Shriners Hospital for Children for evaluation of possible Marfan syndrome.
Controls for this study consisted of unrelated healthy individuals or patients with
neurological (e.g. Alzheimer’s disease) or other musculoskeletal disorders without spine
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involvement (e.g. limb deformity). For the exome sequencing screen, we selected 337 controls
of European ancestry.

Additional in-house controls of European (N=249) or Han Chinese

(N=83) ancestry were included in subsequent analyses.

Individuals of European ancestry

(N=4,300) were included from the Exome Variant Server, NHLBI GO Exome Sequencing
Project (ESP) (http://evs.gs.washington.edu/EVS) public database as an additional control cohort
(ESP6500SI-V2).

Exon enrichment and sequencing
Exon enrichment was performed using the SureSelect Human All Exon 38Mb and 50Mb
kits (Agilent Technologies, Santa Clara, California) or the TruSeq Exome Enrichment kit
(Illumina, San Diego, California). Exome data was extracted from whole genome sequencing in
a subset of in-house controls. Samples were sequenced on a Genome Analyzer IIx or HiSeq
2000 sequencer (Illumina, San Diego, California) by the Washington University Genome
Technology Access Center.

Targeted capture of FBN1 and FBN2
Target enrichment of FBN1 and FBN2 was performed using the Multiplex Direct
Genomic Selection method (manuscript under review), which utilizes multiplexed capture [6]
with targeted selection using bacterial artificial chromosomes (BACs) [7] and next-generation
sequencing. DNA samples (300ng) were sonicated using a Covaris E210 focus-ultrasonicator
(Covaris Inc., Woburn, Massachusetts).

Samples were indexed using previously described

adapter sequences [6]. Indexed samples were pooled in batches of 48-96 prior to capture. Four
BACs spanning the entire coding regions of FBN1 (RP11-1144G24 [chr15:48676783-48822143]
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and RP11-147E14 [chr15:48822351-48985158]) and FBN2 (RP11-909P14 [chr5:127,567,172127,756,046] and RP11-351A8 [chr5:127,752,763-127,906,815]) (BACPAC Resources Center,
Oakland, California) were used as baits. BACs were biotinylated using nick translation with
biotin-16-dUTP (Roche Applied Science, Penzberg, Germany). Pooled samples were hybridized
with biotinylated BACs. Dynabeads M-280 Streptavidin (Life Technologies Co., Carlsbad,
California) were used to isolate BAC-associated DNA. Post-capture, pooled samples were
sequenced using a MiSeq Personal Sequencer (Illumina, San Diego, California).

Alignment and variant calling
Next generation sequencing reads were aligned to hg19 human reference sequence
(Genome Reference Consortium Human Build 37) using Novoalign software (Novocraft
Technologies, Selangor, Malaysia).
SAMtools

[8]

Variant calling and annotation were completed using

and

SeattleSeq

(http://snp.gs.washington.edu/SeattleSeqAnnotation131), respectively.

Annotation

131

All AIS cases and in-

house controls were analyzed using an identical methodology.

Quality control and gene burden analysis
For all analyses, variants were defined as rare when absent from the dbSNP database
(build 137). Analysis was restricted to variants altering the coding sequence (nonsense, splicesite, missense and insertion/deletion mutations). We used a collapsing approach to measure gene
burden [9]. Rare variant burden was quantified as the sum of all variant alleles for each gene
divided by the total alleles in the population and is expressed as the collapsed minor allele
frequency (cMAF).
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For the exome sequencing screen, only AIS cases and in-house controls with ≥90% of the
exome covered at ≥8X coverage were included in the analysis. Variant calls were merged at all
sites and filtered for sites called in >80% of individuals. Gene burden analysis was performed
exome-wide for each gene with at least one variant site.
For gene burden analysis of FBN1 and FBN2 in the larger dataset, more conservative
quality thresholds were applied. Only individual samples with ≥95% of FBN1 (NM_000138) or
FBN2 (NM_001999) covered at ≥8X read depth were included. Low quality variants (phredscaled quality score <30 or genotype quality score <75) were removed. Controls from the ESP
were similarly analyzed using build 137 of the dbSNP database as a filter, which does not
include individuals from this dataset. In the Han Chinese patient cohort, variants identified in
dbSNP or in 83 Han Chinese controls were excluded from analysis. All rare variants in AIS
cases were validated by Sequenom MassARRAY (Sequenom, San Diego, California) by the
Washington University Human Genetics Division of Genotyping Core or by Sanger sequencing
using an ABI 3730 Sequencer (Life Technologies, Carlsbad, California). All genotyped variants
(N=32) validated.

Statistical analysis
One-tailed P-values <0.05 were considered statistically significant. A Fisher’s exact test
was used for all gene burden analyses. The Shapiro-Wilk test demonstrated non-normally
distributed clinical characteristics (P<0.05), therefore, the Mann-Whitney-Wilcoxon test was
used to compare clinical features, except gender and AIS family history, which were compared
using a Fisher’s exact test. Statistical tests were performed with GraphPad Prism software
(http://www.graphpad.com/scientific-software/prism).
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Protein immunoblotting
Immunoblotting was performed using paraspinous muscle collected during surgery for
scoliosis (AIS and Marfan syndrome) or for a ruptured spinal disc in a patient without scoliosis
(unaffected control). All samples were collected from females between 9 and 18 years old.
Denatured protein (200µg) was separated on a 7.5% gel by SDS-PAGE and transferred to a
nitrocellulose membrane. Rabbit polyclonal antibody to pSmad2 (1:1,000; EMD Millipore Co.)
and mouse monoclonal antibody to actin (AC1-20.4.2; 1:2000; Sigma-Aldrich Co.) were used.
Chemiluminescent signals in AIS cases and Marfan syndrome were quantified using ImageJ
[10]. Phospho-SMAD2 signal was normalized to actin and the unaffected control.
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RESULTS

Exome sequencing screen identifies FBN1 and FBN2 as a candidate genes for severe AIS
To identify candidate genes for AIS, exome sequencing was performed on 91 AIS cases
with severe scoliosis (spinal curves measuring ≥40° or surgically treated). We restricted our
analysis to AIS patients with severe scoliosis to reduce the likelihood of latent disease in the
control population, thus increasing power of the association [11]. Furthermore, identifying
genetic variants associated with severe AIS has important clinical utility. Cases in this cohort
had an average spinal curve of 60.2° (SD=15.2°) and 84% were female. The female bias is
consistent with previous studies, where female-to-male ratios are estimated to be as high as 10:1
with severe deformity [12]. Exome sequencing data was also generated for 337 controls. All
cases and controls were unrelated and of European ancestry. Only coding variants that caused
nonsense, splice-site, missense or insertion/deletion mutations which were rare (defined as being
absent in dbSNP) were included in the analysis. This filtering strategy was selected to enrich in
mutations that are very rare and most likely to be deleterious.
Using a gene-burden analysis, we compared the genome-wide frequency of rare coding
variants in severe AIS cases and controls. Of nearly 13,000 genes identified with at least one
rare variant, FBN1 (encoding fibrillin-1) was the most significantly associated gene with AIS
compared to controls (P=3.17×10-4, Fisher’s exact test). The collapsed minor allele frequency
(cMAF) for all rare variants in FBN1 was 0.044 in cases (N=91), compared to 0.005 in controls
(N=337) (OR=10.4, 95% CI=2.7-39.5). This result was surprising, as mutations in FBN1 are
associated with Marfan syndrome (MIM 154700), an autosomal dominant and highly penetrant
disorder that causes skeletal, ocular and cardiovascular phenotypes. Likely a result of the small
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sample size, the association did not reach exome-wide significance (P<2.5×10-6). However,
FBN1 was a compelling candidate for AIS because 63% of Marfan syndrome patients develop
scoliosis [13]. Congenital contractural arachnodactyly (MIM 121050) is a related disorder that
has large phenotypic overlap with Marfan syndrome, including scoliosis which develops in 50%
of patients [14], and is caused by autosomal dominant mutations in fibrillin-2 (FBN2). FBN2
showed weak association with AIS in our exome sequencing screen (cMAF=0.022) compared to
controls (cMAF=0.004) (P=0.0404, Fisher’s exact test), but was also a compelling candidate for
AIS due to a recent genome-wide association study that identified an FBN2 single nucleotide
polymorphism (SNP) among the top 100 SNPs associated with AIS [15].

Rare coding variants in FBN1 and FBN2 are enriched in severe AIS
Based on the results of our exome sequencing screen, FBN1 and FBN2 were selected as
candidate genes to study in a larger cohort. Both genes were sequenced in additional AIS
patients and controls using a newly described targeted capture approach. In total, 323 severely
affected AIS cases and 493 controls of European descent were analyzed for rare variants in
FBN1 or FBN2. All cases and controls had ≥95% coverage at ≥8X read depth to be included in
the gene analysis. The average spinal curve in the AIS cohort was 57.4° (SD=12.1°). As an
independent control cohort, we also identified rare variants in FBN1 and FBN2 for 4,300
individuals of European ancestry from the NHLBI GO Exome Sequencing Project (ESP)
controls (N=4,300).
For FBN1, rare variants were enriched in AIS cases (cMAF=0.021) compared to both inhouse controls (cMAF=0.005) (P=0.0041, Fisher’s exact test) and ESP controls (cMAF=0.005)
(P=8.14×10-5, Fisher’s exact test) (Table 3.1). Thirteen AIS patients (4.2%, N=13/311) and five
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in-house controls (1.0%, N=5/489) were identified with a rare variant in FBN1. An estimated
1.0% (N=44/4300) of ESP controls had a rare FBN1 variant (assuming each individual harbored
only one variant). All AIS variants were heterozygous and caused missense amino acid changes
throughout the FBN1 protein (Figure 3.1A, Table 3.2). Segregation was evaluated for nine families
where DNA was available from one or more additional family members (Figure 3.2). Variants segregated
with AIS in some families. Two variants (p.G1217S and p.G1313S) were located in the neonatal

region of FBN1 (exons 24-32), which is typically associated with a more severe, early-onset
form of Marfan syndrome [16,17]. Three variants were previously reported in Marfan syndrome
(p.L1405R [18],

p.M1576T [19,20] and p.I2585T [18,21,22]) and one of these variants

(p.M1576T) was recurrent in three AIS patients (Table 3.2). Variants previously reported in
Marfan syndrome were also identified in the ESP cohort (p.D1479E [18], p.E2019K [23],
p.R2554W [24], p.R2694Q [25] and p.S2832G [25]) whereas none of the in-house control
variants were previously reported as pathogenic.
Similarly, rare FBN2 variants were also enriched in AIS cases (cMAF=0.017) compared
to in-house controls (cMAF=0.006) (P=0.0307, Fisher’s exact test) and ESP controls
(cMAF=0.007) (P=0.0054, Fisher’s exact test) (Table 3.1).

Eleven AIS patients (3.5%,

N=11/316), five in-house controls (1.2%, N=5/427) and approximately 1.3% (N=56/4300) of
ESP controls were identified with a variant in FBN2. All AIS variants were heterozygous and
caused missense mutations, except for a five base insertion present in one AIS case (Figure 3.1B,
Table 3.2). DNA was available for one or more additional family members in seven families. Variants
segregated in some families (Figure 3.2). In congenital contractural arachnodactyly, pathogenic

mutations are limited to the neonatal region (exons 23-34) [26]. In contrast, variants identified in
AIS patients were located throughout the protein, including the neonatal region (p.R1021C,
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p.I1116S, p.L1125V and p.G1271A). None of the variants identified in AIS cases or controls
were previously reported in congenital contractural arachnodactyly.
Combining rare variants from both FBN1 and FBN2 yielded a cMAF of 0.039 in AIS
cases, 0.012 in controls (P=5.46×10-4, Fisher’s exact test) and 0.012 in ESP controls (P=1.48×106

, Fisher’s exact test) (Table 3.1). Only one AIS case and none of the in-house controls had a

variant in both FBN1 and FBN2. Thus, variants in either FBN1 or FBN2 were identified in 7.6%
(N=23/304) of AIS cases, 2.4% (N=10/425) of in-house controls and approximately 2.3%
(N=100/4300) of ESP controls.
In addition to AIS cases with severe scoliosis, we also sequenced 112 AIS cases of
European ancestry with mild to moderate scoliosis (curve <40°). The average spinal curve in
this cohort was 28.1° (SD=6.9°). Rare variants in FBN1 and FBN2 were identified in 1.9%
(N=2/106) and 0.9% (N=1/107), respectively, of the mild to moderately affected AIS cases
(Figure 3.1A, Figure 3.1B, Table 3.2). FBN1 and FBN2 rare variant frequencies were not
significantly different in mild to moderate AIS cases compared to in-house controls (P=0.47,
Fisher’s exact test) or ESP controls (P=0.42, Fisher’s exact test).

Distinct clinical features of AIS patients with rare fibrillin variants
To determine if AIS patients with rare fibrillin variants manifest unique clinical
characteristics, we compared patients with variants in FBN1 (N=15) and FBN2 (N=12) to
patients without rare variants in either gene (N=379) (Table 3.3). Analysis was limited to
individuals of European ancestry, but included all curve severities (≥10°). The average spinal
curve was 20° greater in AIS patients with an FBN1 variant compared to other patients
(P=6.91×10-4, Mann-Whitney-Wilcoxon test). All 15 AIS patients with rare FBN1 variants
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developed scoliosis with a Cobb angle of ≥35° (Table 3.2), which would typically warrant
bracing or surgery. FBN1 variants were also associated with taller stature standardized to age
and gender (P=0.0035, Mann-Whitney-Wilcoxon test). Of all AIS patients in this cohort with
height ≥90th percentile, 22.5% (N=9/40) were found to have a rare FBN1 variant. Rare FBN1
variants were also associated with Marfan-associated features, which were quantified using the
revised Ghent criteria [4] (P=0.0072, Mann-Whitney-Wilcoxon test). Gender, weight, body
mass index, family history of treated AIS and joint hypermobility were not associated with the
presence of rare FBN1 variants. There were no unique clinical characteristics in AIS patients
with rare FBN2 variants (Table 3.3). However, like FBN1, we noted a trend towards greater
spinal curves in AIS patients with FBN2 variants (P=0.10).

Curve severity is associated with rare fibrillin variants in AIS cases of European and Han
Chinese ancestry
AIS patients of European ancestry with a rare variant in either FBN1 or FBN2 (N=26)
developed an average spinal curve of 64.0°, compared to 49.0° in cases with no rare variants
(N=364) (P=0.0012, Mann-Whitney-Wilcoxon test) (Figure 3.3).

Because predicting curve

severity has important clinical implications, we performed a replication study in 370 Han
Chinese AIS patients. Our replication cohort included all curve severities ≥10° (average=34.1°,
SD=12.5°). Twenty-eight (7.6%, N=28/370) Han Chinese cases were identified with a rare
coding variant in FBN1 or FBN2. The average spinal curve in these cases (37.2°, N=28) was
greater than cases with no rare variant in FBN1 or FBN2 (33.9°, N=342) (P=0.0376, MannWhitney-Wilcoxon test) (Figure 3.3). Moreover, 11.9% (N=12/101) of Han Chinese cases with
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severe spinal curves measuring ≥40° had a rare variant in FBN1 or FBN2, compared to only
5.9% (N=16/269) of cases with spinal curves <40° (P=0.04826, Fisher’s exact test).
AIS cases of other ancestral background (N=47) were also sequenced in this study and an
additional five rare variants in FBN1 and FBN2 were identified (Figure 3.1A, Figure 3.1B, Table
3.2). In all ancestries, the average spinal curve in AIS cases with a rare FBN1 or FBN2 variant
was 50.5° (N=59), compared to 42.1° in cases with no fibrillin variant (N=742) (P=0.0026,
Mann-Whitney-Wilcoxon test) (Figure 3.3).

Evaluation of Marfan syndrome in AIS patients with FBN1 variants
Pathogenic mutations in Marfan syndrome result in progressive dilation of the aorta,
which predisposes individuals to aortic aneurysms and dissections [4].

Because the life-

threatening cardiovascular complications of Marfan syndrome are preventable, it is currently
recommended that known or expected pathogenic mutations identified incidentally during
clinical sequencing are reported [27]. Therefore, AIS patients with rare FBN1 variants were
referred for additional evaluations assessing potential Marfan syndrome. Nine patients agreed to
additional evaluations and were subsequently assessed by a clinical geneticist (Table 3.4). Three
AIS patients had Marfan syndrome-associated mutations (p.L1405R, p.M1576T and p.I2585T)
and six patients had variants of unknown significance (p.N280T, p.Q697R, p.N703H, p.N2178K,
p.Y2225F and p.V2868I). The revised Ghent nosology [4] was employed. AIS patients were
between 10 and 24 years old at time of evaluation. Seven patients had imaging studies for aortic
root dilation and five patients received a dilated eye exam. Two AIS patients received physical
examinations but no cardiac imaging studies. Familial DNA was available for genotyping in nine
families. The FBN1 variant was inherited in eight families and one family was inconclusive (Figure 3.2).
None of the AIS patients reported significant features suggestive of Marfan syndrome (ectopia lentis,
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unexplained death, aortic dissection or aortic aneurysm) in any family members. Nonspecific features of
Marfan syndrome (e.g. pectus deformity, hypermobility) were present in some family members. Only

one of the nine patients that received additional evaluation met the diagnostic criteria for Marfan
syndrome. This patient (6386001) had aortic root dilation (Z-score=2.6) and significant Marfanassociated systemic features (Ghent systemic features score=10) (Table 3.4). Of all patients of
European descent evaluated for systemic features (N=118), 6386001 was the only patient that
scored ≥7, which is considered clinically significant [4]. The mutation identified in 6386001
(p.I2585T) was previously described in multiple individuals with Marfan syndrome [18,21,22].

Increased pSMAD2 in paraspinous muscle of AIS patients with rare FBN1 variants
Previous studies have shown that pathogenic FBN1 mutations causing Marfan syndrome
result in upregulated transforming growth factor beta (TGF-β) signaling that can be measured in
plasma or indirectly measured through activation of downstream targets, such as phosphorylation
of SMAD2 (pSMAD2) [28-31]. To determine if AIS patients with rare FBN1 and FBN2 variants
also have upregulated TGF-β, we used western blotting to examine pSMAD2 levels in
paraspinous muscle from three AIS cases harboring a variant in FBN1 (p.P1225L, p.M1576T and
p.G2003R) and one AIS case with a rare variant in FBN2 (p.P740H) (Figure 3.4). Paraspinous
muscle was also collected for a patient diagnosed with Marfan syndrome (positive control) and
an unaffected individual who did not have scoliosis (negative control).

Compared to the

unaffected control, pSMAD2 was elevated in all AIS patients with rare FBN1 variants and in the
Marfan syndrome patient. We observed similar pSMAD2 levels the AIS patient with a rare
FBN2 variant compared to the unaffected control.
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DISCUSSION

Pathogenic mutations in FBN1 are most frequently associated with Marfan syndrome
[32] where over 1,000 mutations have been described [33], but mutations in FBN1 have also
been reported in ectopia lentis syndrome [34], isolated aortic aneurysm [35-38], ShprintzenGoldberg syndrome [39], Weill-Marchesani syndrome [40], geleophysic and acromicric
dysplasia [41], stiff skin syndrome [42] and MASS phenotype (myopia, mitral valve prolapse,
borderline aortic root dilation, skeletal and skin findings) [43].

Mutations in FBN2 have

previously been associated only with congenital contractural arachnodactyly [44]. In the current
study, we demonstrate an important role for FBN1 and FBN2 in the pathogenesis of AIS,
broadening the spectrum of fibrillin-related disorders.
Until now, the majority of FBN1 and FBN2 sequencing studies have been limited to
select cohorts of patients with suspected Marfan syndrome and congenital contractural
arachnodactyly, particularly because the cost of sequencing FBN1 and FBN2, each consisting of
~11kb of coding sequence spread over 65 exons, is prohibitively high in large cohorts. However,
FBN1 mutations were previously described in a family with isolated kyphoscoliosis [45] and a
family with isolated skeletal features including scoliosis [46] suggesting that fibrillin might
contribute to isolated skeletal phenotypes, like AIS. In addition, earlier investigations revealed
fibrillin abnormalities in the fibroblasts of AIS patients [47], but linkage analysis did not support
segregation of the FBN1 locus in large AIS pedigrees [48] and further genetic studies in AIS
were not pursued.
Using exome sequencing and a cost-effective targeted capture approach to sequence
FBN1 and FBN2, we found that the burden of FBN1 and FBN2 rare variants is relatively high in
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severely affected AIS patients, with 7.6% of patients of European ancestry having a rare variant
in either gene, over three-times the frequency of controls (2.4%). Curve severity was the most
striking clinical finding that distinguished patients with rare fibrillin variants, leading to spinal
curves that were on average 15° larger than observed in other AIS patients. Interestingly,
scoliosis is common in patients with Marfan syndrome [13] and congenital contractural
arachnodactyly [14] and, like the AIS cases studied here, often progresses to severe curves
[49,50]. Our findings indicate that FBN1 and FBN2 variants could serve as prognostic genetic
markers to predict scoliosis progression. This has important clinical utility because of the
potential to develop personalized prevention strategies for those at high risk of severe deformity
and to eliminate screening and treatment for patients at low risk [51-53].
In addition to spinal curve progression, we found that rare FBN1 variants are also
associated with tall stature in the AIS population. Because nearly one-quarter of AIS cases in
our study with height ≥90th percentile had a rare FBN1 variant, this easily obtainable clinical
measure can identify patients who are particularly likely to harbor these genetic variants and may
benefit from FBN1 sequencing studies. We also found that AIS patients with FBN1 variants
collectively scored higher using the Ghent systemic features scoring system [4], which evaluates
several nonspecific physical traits that are common in Marfan syndrome.

However, the

differences were small and the systemic features score is unlikely to be useful for identifying
individual AIS patients with rare FBN1 variants. Despite this, our data confirm that the systemic
features scores do have utility as a screen for unrecognized Marfan syndrome in the AIS
population, as the only patient with a clinically significant systemic feature score (≥7) was
identified with an FBN1 mutation and subsequently diagnosed with Marfan syndrome as a part
of this study after additional clinical testing.
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While FBN1 mutations causing Marfan syndrome are associated with life threatening
cardiovascular complications, our data suggest that the majority of AIS-associated variants are
associated with a more benign course. First, physical findings were not suggestive of Marfan
syndrome in most patients (N=8/9) and, had these patients been evaluated without knowledge of
FBN1 mutation status, Marfan syndrome would not have been suspected and FBN1 testing
would not have been recommended based on clinical genetics evaluations alone. Second, the
majority of patients who received imaging studies of the aorta showed no evidence of aortic
dilation (N=6/7), which is the cardinal feature of Marfan syndrome. Third, family histories did
not endorse Marfan syndrome. Rare FBN1 variants were inherited from a parent in at least seven
families, but no patient reported family members with features suggestive of Marfan syndrome,
including aortic dilation, aortic aneurysm or dissection, ectopia lentis, or unexplained death.
However, despite little evidence supporting a diagnosis of Marfan syndrome in most AIS
patients with rare FBN1 variants, one AIS patient not previously suspected of the disorder was
diagnosed as a direct result of this study. Because there are treatments available to prevent the
life-threatening aortic complications of Marfan syndrome (e.g. losartan [28,54-56]), recognition
of the disorder can significantly affect patient outcomes. Unfortunately, for AIS patients with
FBN1 variants who did not fulfill the diagnostic criteria at the time of examination, the absence
of aortic dilation does not conclusively rule out Marfan syndrome and aortic dilation may
develop later in life [4]. Ongoing screening of all AIS patients with rare FBN1 variants is
therefore warranted and is consistent with the current recommendations for patients with FBN1
mutations who do not fulfill diagnostic criteria [23,57]. Regardless of the long-term risks
associated with rare FBN1 variants, FBN1 sequencing in the AIS population is likely to have
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clinical value, either as an early indicator of potential Marfan syndrome or as a predictor of
progressive AIS.
Congenital contractural arachnodactyly does not appear to be associated with the same
risk of life-threatening cardiovascular complications as Marfan syndrome; however, aortic
dilation has been described in several patients and echocardiographic evaluations are currently
recommended [26]. AIS patients with rare FBN2 variants did not receive additional clinical
evaluation, but patient histories did not indicate “crumpled” ears, muscular hypoplasia,
contractures of the major joints or other features that would be suggestive of congenital
contractural arachnodactyly.
Although our findings suggest that rare variants in FBN1 and FBN2 are associated with
AIS rather than unrecognized Marfan syndrome or congenital contractural arachnodactyly,
additional long-term studies of AIS patients with fibrillin abnormalities are needed. Such studies
would clarify the potential future complications, if any, associated with rare fibrillin variants and
inform the interpretation of incidentally identified FBN1 and FBN2 variants in future diagnostic
or research studies.
FBN1 and FBN2 are expressed with significantly overlapping patterns beginning during
early development (see review [58]) and the biological mechanism leading to scoliosis when
FBN1 and FBN2 are mutated remains unclear, even in cases of Marfan syndrome and congenital
contractural arachnodactyly. Aberrant activation of the TGF-β pathway has been observed in
Marfan syndrome [30] and may be responsible for some of the skeletal features, like tall stature
[59]. We found that AIS patients with FBN1 variants were also tall, which suggests that these
protein changes also alter TGF-β signaling. We showed upregulation of the TGF-β pathway in
paraspinous muscle of three AIS patients with rare FBN1 variants, confirming that at least some
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of the variants identified in AIS have functional effects. Recent studies have shown that FBN2
also regulates TGF-β signaling [60], but we did not observe upregulation of TGF-β in muscle
from an AIS patient with a rare FBN2 variant, suggesting that the variant may not have an effect
on this aspect of FBN2 function. Unfortunately, we did not have access to muscle on a larger
cohort of AIS patients and further studies will be required to demonstrate more definitively that
these gene variants activate the TGF-β pathway. Interestingly, the TGF-β pathway is also
upregulated in patients with Loeys-Dietz syndrome [61,62], a disorder that has many overlapping
features with Marfan syndrome and congenital arachnodactyly and is highly associated with
scoliosis [63]. Because scoliosis is a common feature of several Mendelian disorders involving
the TGF-β signaling pathway, other genes in the TGF-β pathway may be good candidates for
AIS, which is supported by a recent study that identified transforming growth factor beta-1 as a
novel susceptibility gene for AIS [64]. Moreover, an association of TGF-β signaling with AIS
could explain why other Marfan-associated features are observed more frequently in AIS patients
than in the general population, including tall stature [65], joint hypermobility [66], pectus
excavatum [67,68] and dural ectasia [69], Recent studies in mouse models and humans with
Marfan syndrome have shown promising developments in therapeutic strategies to reduce the
hyper-activated TGF-β pathway, including TGF-β neutralizing antibody and the angiotensin II
type 1 receptor blocker, losartan [28,54-56]. The potential link between AIS and the TGF-β
signaling pathway suggests the possibility that drugs like losartan may someday be useful to treat
AIS cases in which the TGF-β pathway is activated.
In summary, we demonstrate an important role for FBN1 and FBN2 in AIS pathogenesis.
We show that rare variants are enriched in severely affected AIS patients and are significantly
associated with curve severity. Because reliable methods for predicting scoliosis progression are
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not currently available, these results have immediate clinical utility. Furthermore, we show
altered TGF-β signaling in AIS patients with fibrillin mutations, which opens up the possibility
of novel treatments that have not previously been considered for AIS.
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Figure 3.1: Rare FBN1 and FBN2 variants identified in AIS patients
Protein structure of FBN1 and FBN2 (redrawn [70]). (A) Missense variants were identified
throughout FBN1 in AIS patients of European descent (N=417) and other ancestries (N=47).
Variants previously associated with Marfan syndrome are in bold. (B) Missense and other
coding changes were identified in FBN2 in AIS patients of European (N=423) and other
ancestries (N=47). Asterisk indicates variants identified in other ancestries.
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Figure 3.2: Segregation of FBN1 and FBN2 variants
Variant segregation was evaluated for AIS families with two or more individuals available for
genotyping. The presence of AIS resulting in bracing or surgery (treated AIS), AIS that
measured <20° or was self-reported and not treated (mild AIS) and other features of Marfan
syndrome and congenital contractural arachnodactyly (pectus carinatum, pectus excavatum,
hypermobility, spondylolisthesis) are shown.
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Figure 3.3: Rare FBN1 and FBN2 variants are associated with curve severity in AIS
The average spinal curve was determined for AIS cases with a rare variant in either FBN1 or
FBN2 (Variant) and AIS cases without a rare variant in either gene (No variant). AIS cases of
European ancestry (N=405), Han Chinese ancestry (N=370) and a combined analysis consisting
of cases of European, Han Chinese and other ancestries (N=801) consistently showed that
patients with rare variants in FBN1 or FBN2 developed larger spinal curves. Asterisk indicates
the following P-values: *<0.05, **<0.01.
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Figure 3.4: Elevated pSMAD2 in AIS patients with rare FBN1 variants
Paraspinous muscle from an unaffected control, AIS cases with rare variants in FBN1 or FBN2
and a Marfan syndrome patient were immunostained for pSMAD2. pSMAD2 was elevated in
AIS cases with rare FBN1 variants at levels similar to Marfan syndrome. pSMAD2/actin ratio is
shown normalized to the unaffected control.
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Table 3.1: Rare variant frequencies for FBN1 and FBN2 in AIS cases and controls of European ancestry
AIS cases (≥40°)

Controls (this study)

Controls (ESP)

N

Variant
alleles

cMAF

N

Variant
alleles

cMAF

Odds ratio
(95% CI)

P-value

N

Variant
alleles

cMAF

Odds ratio
(95% CI)

P-value

FBN1

311

13

0.021

489

5

0.005

4.2 (1.5-11.7)

P=0.0041

4,300

44

0.005

4.2 (2.2-7.7)

P=8.14×10-5

FBN2

316

11

0.017

427

5

0.006

3.0 (1.0-8.7)

P=0.0307

4,300

56

0.007

2.7 (1.4-5.2)

P=0.0054

FBN
or
FBN2

304

24

0.039

425

10

0.012

3.5 (1.6-7.3)

P=5.46×10-4

4,300

100

0.012

3.5 (2.2-5.5)

P=1.48×10-6

cMAF, collapsed minor allele frequency; ESP, NHLBI Exome Sequencing Project
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Table 3.2: Rare FBN1 and FBN2 variants identified in AIS cases (curve ≥10°)
Case

Scoliosis
curve

Ancestry

Genomic
position (hg19)

Base change

Gene

GVS
function

Amino acid
change

ESP
frequencya

Disease
association

6128001

84°

EUR

chr15:48902952

T>A

FBN1

missense

p.Ile107Leu

-

-

6340001

48°

EUR

chr15:48826300

T>G

FBN1

missense

p.Asn280Thr

-

-

6390001

60°

AFR

chr15:48796007

T>C

FBN1

missense

p.Gln697Arg

-

-

6377001

50°

EUR

chr15:48795990

T>G

FBN1

missense

p.Asn703His

-

-

6016001

36°

Other

chr15:48784766

C>T

FBN1

missense

p.Val916Met

N=1/6,494

-

1044

70°

EUR

chr15:48777634*

C>T

FBN1

missense

p.Gly1217Ser

-

-

6273001

48°

AFR

chr15:48777609*

G>A

FBN1

missense

p.Pro1225Leu

-

-

1083

52°

EUR

chr15:48773879*

C>T

FBN1

missense

p.Gly1313Ser

-

-

chr15:48764870

A>C

FBN1

missense

p.Leu1405Arg

-

MFS [18]

chr15:48760155

A>G

FBN1

missense

p.Met1576Thr

-

MFS [19,20]

6226001

97°

EUR

6272001

90°

EUR

6418001

65°

EUR

6442001

35°

EUR

450-14600

38°

EUR

chr15:48741087

C>T

FBN1

missense

p.Arg1850His

-

-

6320001

66°

EUR

chr15:48736768

C>T

FBN1

missense

p.Gly2003Arg

-

-

6368001

100°

EUR

chr15:48726873

A>T

FBN1

missense

p.Asn2178Lys

-

-

6111001

95°

EUR

chr15:48725128

T>A

FBN1

missense

p.Tyr2225Phe

-

6386001

93°

EUR

chr15:48712949

A>G

FBN1

missense

p.Ile2585Thr

-

6005001

55°

EUR

chr15:48703201

C>T

FBN1

missense

p.Val2868Ile

-

MFS
[18,21,22]
-

6463001

57°

AFR

chr5:127873139

C>T

FBN2

missense

p.Gly53Asp

N=2/6,489

-

6112001

48°

EUR

chr5:127872157

C>T

FBN2

missense

p.Arg92Lys

-

-

1157

45°

EUR

chr5:127782238

A>ACTGTA

FBN2

frameshift

-

-

-

6124001

75°

EUR

chr5:127713520

C>T

FBN2

missense

p.Val592Met

-

-

6279001

55°

EUR

chr5:127704904

G>T

FBN2

missense

p.Pro740His

-

-

1022

25°

EUR

chr5:127681205*

G>A

FBN2

missense

p.Arg1021Cys

-

-

6191001

90°

EUR

chr5:127674750*

A>C

FBN2

missense

p.Ile1116Ser

-

-

6129001

80°

EUR

chr5:127674724*

G>C

FBN2

missense

p.Leu1125Val

-

-

6367001

70°

Other

chr5:127673755*

C>T

FBN2

missense

p.Glu1178Lys

-

-

6229001

65°

EUR

chr5:127671182*

C>G

FBN2

missense

p.Gly1271Ala

-

-

6206001

50°

EUR

chr5:127627260

G>T

FBN2

missense

p.Pro2085Thr

-

-

6383001

43°

EUR

chr5:127613647

T>C

FBN2

missense

p.Ile2466Val

N=1/6,503

-

6418001

65°

EUR

chr5:127609564

A>G

FBN2

missense

p.Phe2603Ser

N=2/6,503

-

-

-

6216001
50°
EUR
chr5:127607792
C>T
FBN2
missense
p.Gly2620Glu
NA, not available; EUR, European; AFR, African; ESP, NHLBI Exome Sequencing Project; MFS, Marfan syndrome
*Neonatal region
a
Frequency includes individuals of African and European ancestry
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Table 3.3: Clinical characteristics of AIS cases (curve ≥10°) of European ancestry with rare
variants in FBN1 and FBN2
No variant

FBN1

P-value

FBN2

P-value

Female

86%
(N=379)

80%
(N=15)

P=0.35

83%
(N=12)

P=0.51

Spinal curve
(avg ± sd)

49° ± 16
(N=364)

69° ± 23
(N=15)

P=6.91×10-4

58° ± 18
(N=12)

P=0.10

Height percentile
(avg ± sd)

55th ± 30
(N=217)

75th ± 31
(N=15)

P=0.0035

56th ± 35
(N=12)

P=0.41

Weight percentile
(avg ± sd)

57th ± 31
(N=217)

69th ± 30
(N=15)

P=0.06

50th ± 33
(N=12)

P=0.25

Body mass index
(avg ± sd)

22.2 ± 5.1
(N=217)

21.6 ± 4.0
(N=15)

P=0.42

20.2 ± 3.6
(N=12)

P=0.06

First degree relative with
treated AIS
Beighton joint
hypermobility score [5]
(avg ± sd)

16%
(N=277)

33%
(N=12)

P=0.12

20%
(N=10)

P=0.50

1.4 ± 1.6
(N=105)

2.5 ± 2.8
(N=10)

P=0.09

1.0 ± 0.8
(N=4)

P=0.45

Ghent systemic features
score [4] (avg ± sd)

2.4 ± 1.4
(N=105)

4.2 ± 2.6
(N=10)

P=0.0072

3.5 ± 1.9
(N=4)

P=0.10

avg, average; sd, standard deviation
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Hypermobility evaluation

Marfan syndrome evaluation

FBN1

General patient information

Table 3.4: Clinical features of AIS patients evaluated for Marfan syndrome
Case

6340001

6390001

6377001

6226001

6418001

6368001

6111001

6386001

6005001

Ancestry

EUR

AFR

EUR

EUR

EUR

EUR

EUR

EUR

EUR
F

Gender

M

F

F

F

F

F

M

F

Age (years)

13

14

17

18

14

10

13

15

th

th

th

st

th

th

rd

th

24

Height (percentile)

>99

70

57

91

>99

>99

93

98

91st

Weight (percentile)

99th

96th

62nd

85th

87th

88th

86th

92nd

95th

Spinal curve

48°

60°

50°

97°

65°

100°

95°

93°

55°

Curve type

R-T

R-T

R-TC

R-T

R-T

R-T

L-T

R-T

R-T

Treatment

none

surgery

surgery

surgery

surgery

surgery

surgery

surgery

surgery

FBN1 variant

p.N280T

p.Q697R

p.N703H

p.L1405R

p.M1576T

p.N2178K

p.Y2225F

p.I2585T

p.V2868I

Variant reported in MFS

No

No

No

Yes

Yes

No

No

Yes

No

MFS diagnosis

No

No

No

No

No

No

No

Yes

No

Aortic root dilation

-

NA

NA

-

-

-

-

+

-

Ectopia lentis

-

NA

NA

NA

-

NA

-

-

-

Systemic features score

3/22

3/17

1/17

2/20

4/18

2/22

5/18

10/22

6/18

Pectus deformity

-

-

-

-

-

-

-

-

-

Hindfoot deformity

-

-

-

-

-

-

-

+

+

Pes planus

-

+

-

-

+

-

+

+

+

Wrist/thumb sign

-

-

-

-

-

-

-

+

-

Upper/Lower segment

1.17

0.93

0.97

1.00

0.95

0.88

0.85

0.76

0.99

Arm span/Height

1.03

1.08

0.98

1.01

1.01

1.03

1.07

1.09

1.02

Reduced elbow extension

-

-

-

-

+

-

-

-

-

Dural ectasia

-

NA

NA

-

NA

-

NA

-

NA

Protrusio acetabuli

-

NA

NA

NA

NA

-

NA

-

NA

Skin striae

+

+

-

+

+

-

+

+

+

Facial features (3/5)

-

-

-

-

-

-

-

-

-

Myopia

+

-

-

-

-

-

+

+

+

Pneumothorax

-

-

-

-

-

-

-

-

-

Mitral valve prolapse

-

NA

NA

-

-

-

-

-

-

Hypermobility score

0/9

0/9

1/8

4/8

1/9

2/9

2/8

2/9

9/9

Hands flat on floor

-

-

-

NA

-

-

-

-

+

L knee overextends

-

-

-

-

-

-

+

-

+

R knee overextends

-

-

-

-

-

-

+

-

+

L elbow bends >10°

-

-

-

-

-

-

-

-

+

R elbow bends >10°
L thumb touching
forearm
R thumb touching
forearm
L little finger >90°

-

-

-

-

-

-

-

-

+

-

-

+

+

-

+

-

+

+

-

-

NA

+

+

+

NA

+

+

-

-

-

+

-

-

-

-

+

R little finger >90°

-

-

-

+

-

-

-

-

+

+, present; -, absent; L= left; R= right; T= thoracic; TC= thoracolumbar; EUR, European; AFR, African; MFS, Marfan syndrome; NA= not available
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Chapter 4:
Kinesin Family Member 6 (kif6) is Necessary for Normal
Vertebral Development in Zebrafish
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SUMMARY

Idiopathic scoliosis is a common condition in humans that causes spinal deformity in 23% of the at risk population.

The pathogenesis of idiopathic scoliosis remains poorly

understood, in part due to the lack of a relevant animal model. To identify a zebrafish model for
idiopathic scoliosis, we performed a forward mutagenesis screen and identified skolios, a
recessive zebrafish mutant with a spinal curvature phenotype. skolios develops an isolated spinal
deformity phenotype that parallels certain features of human idiopathic scoliosis, including a
medial-lateral curvature of the spine that arises independent of vertebral malformations. To
identify the genetic basis of skolios, we used meiotic mapping to narrow the locus to a 2.7 Mb
region on chromosome 17. Low-coverage whole genome sequencing was then used to identify
candidate mutations within the mapped locus. Twenty homozygous nonsynonymous mutations
were identified in the locus. Only one nonsynonymous change resulted in a nonsense mutation,
which caused a premature stop in kinesin family member 6 (kif6), a poorly characterized kinesin
of unknown function. To confirm that loss of kif6 is responsible for the skolios phenotype, we
created additional mutant alleles using transcription activator-like effector nucleases (TALENs).
Three new TALEN-induced mutations causing frameshift mutations in kif6 were identified. All
zebrafish homozygous or compound heterozygous for kif6 frameshift mutations developed a
scoliosis phenotype that was indistinguishable from skolios mutants, confirming kif6 as the
causative gene. Although kif6 may play a role in cilia, no evidence for cilia dysfunction was
seen in skolios mutants.

Overall, these findings demonstrate a novel role for kif6 in the

developing spine and identify a new candidate gene for human idiopathic scoliosis.
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INTRODUCTION

Idiopathic scoliosis is a multifaceted genetic disorder that causes curvature of the spine in
2-3% of humans, with about 10% of patients progressing to deformity warranting bracing or
surgical treatment. Although idiopathic scoliosis is defined by a deviation of the spine from the
midline in the medial-lateral plane, curvature is typically complex and causes a three
dimensional deformity affecting all three planes (medial-lateral, dorsal-ventral and transverse).
Unlike secondary scoliosis that arises from congenital vertebral malformations or other
syndromic conditions, idiopathic scoliosis is poorly understood and no obvious structural
vertebral abnormalities are present. A major challenge in determining the pathogenesis of
idiopathic scoliosis has been the lack of a relevant animal model. Animal models of idiopathic
scoliosis have been primarily limited to experimental forms of scoliosis, where scoliosis is
induced by invasive surgical procedures, immobilization or the use of the systemic agents [1].
Because spinal deformity develops secondary to harsh interventions, experimentally induced
forms of scoliosis are unlikely to recapitulate many features of human idiopathic scoliosis.
With the exception of humans, naturally occurring scoliosis is relatively rare [2].
Humans ambulate in an upright position with their center of gravity over the pelvis, a
characteristic that is unique even among other primates [3].

This erect, bipedal posture

significantly alters the dorsal shear loads of the spine, which has been proposed as an important
prerequisite for scoliosis development [4].

In support of this model, pinealectomized rats

develop scoliosis when also made bipedal, whereas similarly treated quadrupedal rats do not [5].
Although pinealectomy and bipedalism may be important prerequisites for scoliosis in some
species, pinealectomy in bipedal nonhuman primates does not cause spinal deformity [6].
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Moreover, pinealectomy in guppy [7] and salmon [8] induces spinal curvature similar to bipedal
rats, demonstrating that scoliosis induced by pinealectomy does not require bipedalism.
A mutant guppy strain, curveback, is one of the few examples of an animal model with
non-induced spinal deformity that parallels human idiopathic scoliosis [7]. curveback mutants
develop a spinal curvature sporadically in the dorsal-ventral and medial-lateral plane that is not
due to vertebral malformations. Sporadic spinal deformity has also been noted in other teleosts,
including medaka and swordtail, suggesting that teleosts may be ideal animal models to identify
and characterize naturally occurring scoliosis [9]. Of the teleosts, zebrafish (Danio rerio) are
particularly well-suited model organisms, as zebrafish are highly tractable and have extensive
genomic resources. Scoliosis in zebrafish has been largely unexplored. The zebrafish mutant
leviathan is caused by recessive mutations in collagen type VIII alpha1a (col8a1a) and develops
scoliosis, although mutants also develop notochord defects and congenital vertebral
malformations [10].

It remains unclear if zebrafish are susceptible to naturally occurring

scoliosis without vertebral malformations. Therefore, we sought to identify novel zebrafish
scoliosis mutants that could serve as a model for human idiopathic scoliosis. Using an N-ethylN-nitrosourea (ENU) mutagenesis forward genetic screen, we identify and describe skolios, a
zebrafish mutant with recessively inherited scoliosis that shares several characteristics with
human idiopathic scoliosis.
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METHODS

Zebrafish maintenance
Zebrafish were maintained under standard conditions [11]. Zebrafish were bred by in
vitro fertilization using adults anesthetized in 0.16% tricaine methanesulfonate (3-amino benzoic
acidethylester, Sigma-Aldrich) diluted in E3 embryo medium (5 mM NaCl, 0.17 mM KCl, 0.33
mM CaCl 2 , MgSO 4 in H 2 0) or by natural pairwise mating. With exception to WIK strains used
for meiotic mapping, all wild-type (WT) zebrafish were from an AB genetic background.
Experiments were carried out in accordance with the animal protocol guidelines at Washington
University.

Chemical Mutagenesis and Forward Genetic Screening
skolios was identified from an ENU mutagenesis screen performed on WT (AB)
zebrafish.

The generation of mutagenized F1 female fish was carried out with ENU as

previously described [12].

Gynogenetic diploids were subsequently derived by the early

pressure method [13] and screened for spinal curvature.

Analysis of spinal and vertebral morphology
MicroCT imaging was performed using a VivaCt40 machine (ScanCo) as previously
described [14].

Zebrafish observations were imaged using an Olympus DP70 Digital

Microscope Camera fixed to an Olympus MVX10 MacroView fluorescence microscope with
MicroSuite Basic Edition software (Olympus). For bone and cartilage staining, zebrafish at
various time points were euthanized with tricaine methanesulfonate and fixed in 4% PFA/PBS.
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Fixed zebrafish were immersed in 0.1% alcian blue in 7:3 EtOH:glacial acetic acid for 2448 hours and destained for 0.5-2 hours in 7:3 EtOH/glacial acetic acid to visualize cartilage.
Bones were then stained with alizarin red S in 0.5% KOH for 6-24 hours and destained in 0.5%
KOH. Stained zebrafish were stored in glycerol. The spinal curvature was quantified by
imaging zebrafish positioned laterally. For consistency, spinal curvature was only quantified
near the transition from abdominal (rib vertebrae) to caudal vertebrae (vertebrae posterior of
ribs), which excluded the most anterior and posterior vertebrae. The apex of the curve was
identified within the defined region and lines were drawn through the center of the two vertebrae
adjacent to the apex. The angle of the two intersecting lines was measured using Photoshop CS3
(Adobe). Measured angles were subtracted from 180° to calculate the spinal curve.

Meiotic mapping and whole genome sequencing
The skolios mutation was localized to chromosome 17 using centromeric linkage analysis
[10,15].

Fine mapping was achieved by mapcrossing to the polymorphic WIK strain and

assessing for recombination along chromosome 17 by sequence length polymorphism analysis
[16]. For whole genome sequencing, genomic DNA from a skolios mutant was extracted using
Proteinase K (Roche) and 25:24:1 phenol:chloroform:isoamyl (Roche) according to the
manufacturer’s instructions.

Whole genome sequencing was performed by the Genome

Technology Access Center at Washington University. One lane of a HiSeq 2000 sequencer
(Illumina) was used to generate 101 bp paired-end reads. Raw sequencing reads were aligned to
the Zv9 genome assembly using Novoalign (Novocraft Technologies). Variants were identified
using SAMtools software [17] and annotated using SnpEff software [18].
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Variants were

validated by Sanger sequencing using an ABI 3730 Sequencer (Life Technologies) and
visualized using Sequencher DNA Sequencing software (Gene Codes).

RT-PCR of adult zebrafish tissues
Tissue samples were harvested from adult zebrafish euthanized in tricaine
methanesulfonate. Tissue samples were dissected and pooled from 5-10 zebrafish and total RNA
was extracted using Trizol Reagent (Invitrogen). RNA concentrations were measured using a
NanoDrop 2000 UV-Vis spectrophotometer. cDNA synthesis was performed using SuperScript
II Reverse Transcriptase (Invitrogen) with 1 µg RNA according to the manufacturer’s
instructions. As a negative control, cDNA synthesis reactions were also performed with the
reverse transcriptase omitted. PCR reactions were performed with Bullseye Taq Polymerase
(Midsci) using 1 µl cDNA and 35-40 amplification cycles with 58° annealing temperature and 30
second extension. The following primers were used:
kif6 (ex1-3)

5’- CGTGCAGGTAAACAGTAAAAGC -3’
5’- CAGCAACAGGTTTTGCAATG -3’

kif6 (ex16-18)

5’-GCGGAGAGAACACAGGAAAC-3’
5’-GTGCTGTTGAGCAGGTTGTG-3’

β-actin

5’-TACAATGAGCTCCGTGTTGC-3’
5’-AAGGAAGGCTGGAAGAGAGC-3’

Microinjection of morpholinos
Morpholinos (MOs) were purchased from Gene Tools, LLC to transiently knock-down
zebrafish kif6. MOs were designed to target the translation start site (trans-block) and the
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boundary between exon 1 and intron 1 (splice-block).

An additional MO targeting the

translation start site but containing a 5 base mismatch served as a negative control (mismatch).
The 3’ end of the splice-blocking and mismatch MOs were modified with a fluorescein tag. The
sequences of the MOs are as follows:
trans-block

5’-TTGCTTTTACTGTTTACCTGCACGT-3’

splice-block

5’-ACAAAAGCAAAACACTCACCGAGGT-3’

mismatch

5’-TGCTTAACGATCTTAATCATCGCTT-3’

MOs were prepared at concentrations ranging from 0.05 mM to 3 mM and approximately 500 pl
were injected in 1-4 cell stage embryos.

Transcription activator-like effector nuclease (TALEN) design and assembly
Two TALENs (left and right) were designed to target the second exon of kif6. These
sites flanked a BccI restriction site that was used for mutation screening.

TALENs were

generated using the Golden Gate method as previously described [19]. Plasmids were acquired
from the Golden Gate TALEN and TAL Effector Kit (AddGene) and RVD repeat arrays were
cloned into pCS2TAL3DD and pCS2TAL3RR (AddGene). Plasmids were transformed into
DH5α competent cells (Invitrogen) and isolated using the QIAprep Spin Miniprep Kit (Qiagen).
The following sequence targets and RVD sites were used to generate kif6 TALENs:
Left target DNA

TCCCTCTTATTGTTG

Left RVD sequence

NG HD HD HD NG HD NG NG NI NG NG NN NG NG NN

Right target DNA

GCATCTCTGGGAACC

Right RVD sequence

NN NN NG NG HD HD HD NI NN NI NN NI NG NN HD

104

Injection of TALEN RNA in zebrafish embryos
Complete plasmids (containing the scaffold and RVD arrays) were linearized using XhoI
and 5’-capped mRNA was generated by in vitro transcription using the mMESSAGE
mMACHINE SP6 Transcription Kit (Life Technologies). Capped mRNA was purified using the
RNeasy Mini Kit (Qiagen). Left and right TALENs were combined at equal concentrations.
WT embryos were collected and 40-50 pg of pooled TALENs were injected into the yolk of 1-4
cell stage embryos. Injected embryos and progeny were screened for TALEN-induced mutations
by digesting PCR amplified DNA with BccI (New England Biolabs). The following primers
were used for screening the BccI restriction site:
BccI

5’TGCAATAAATGGAAACAAGAACC-3’
5’-TTCGCACATTTGTTCAGTGAC-3’

Evaluation of cilia and cilia-related phenotypes
Defects in left-right asymmetry were determined by visualizing the position of the heart
in 30 hpf embryos. Abnormal left-right asymmetry was classified as ambiguous when the heart
was positioned at the midline and as situs inversus when the heart was positioned left of the
midline when viewed ventrally (the right side of the embryo).

Otoliths were evaluated by

visualizing zebrafish laterally between 48-72 hpf. Immunofluorescence staining was performed
as previously described [20] using embryos collected at 28 hours post-fertilization (hpf).
Embryos were dechorionated in protease type XIV (Sigma) and fixed in 4% paraformaldehyde
for immunostaining with anti-acetylated tubulin monoclonal antibody 6-11-B1 (Sigma). Fluid
flow in the central canal was measured as previously stated [21]. Live 48 hpf zebrafish were
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anesthetized in tricaine methanesulfonate and imaged at various time points after injection of 5%
tetramethylrhodamine conjugated to 70,000 molecular weight dextran into the brain ventricle.

Statistical analysis
A one-tailed Student’s t-test was used for all statistical analyses.
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RESULTS

Identification of skolios
To identify zebrafish mutants with scoliosis, we performed an ENU mutagenesis screen
on wild-type (WT) AB zebrafish. From this screen, we identified a new zebrafish mutant,
skolios, which develops recessively inherited curvature of the body axis.
Body curvature first develops in skolios mutants during embryonic hatching stages (2-3
days post-fertilization [dpf]), causing a ventral curvature of the body axis that is frequently
limited to the distal end of the tail (Figure 4.1A). This early curvature arises without observable
defects in the notochord (e.g. kinking) and is incompletely penetrant with variable expressivity.
Approximately 20% of skolios embryos appear normal at 3 dpf, while the majority exhibit either
moderate (~70%) or severe (~10%) ventral body curvature (Figure 4.1A, Figure 4.1B).
Unlike the incompletely penetrant ventral body curvature first seen during hatching
stages, curvature in the medial-lateral plane becomes fully penetrant during early larval stages
(4-5 dpf) and progresses through later larval and juvenile stages (5-89 dpf) (Figure 4.1C).
Although there is large phenotypic variability in the appearance and severity of the curve, body
curvature defects are easily observed in both the dorsal-ventral and medial-lateral planes of all
adult skolios mutants (Figure 4.1D). Despite the severity of the deformity, adult skolios mutants
are both viable and fertile. Heterozygous mutants exhibit no overt embryonic or post-embryonic
phenotype.
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Characterization of spinal curvature in skolios mutants
We performed microCT imaging of a skolios mutant and WT zebrafish at 50 dpf to
determine if vertebral abnormalities underlie the curved body axis in skolios. Compared to WT,
the skolios mutant developed a marked curvature of the abdominal and caudal spine in both the
dorsal-ventral and medial-lateral planes (Figure 4.1E).

To evaluate the temporal onset of

curvature and to screen for vertebral defects, we performed a two-staining protocol using alcian
blue, a positively charged dye that is thought to react with the acidic mucopolysaccharides in
cartilage, and alizarin red, a dye that binds to mineralized bone [22]. Vertebral morphology was
evaluated during several developmental time points for WT and skolios mutants. To track the
progression of the spinal curve, curves were measured in the dorsal-ventral plane as shown in
Figure 4.2A. Although human idiopathic scoliosis is measured in the medial-lateral plane,
individual zebrafish vertebrae were more easily observed when viewed laterally, which allowed
for more accurate curve measurements. All curves were measured at the curve apex near the
transition from abdominal to caudal vertebrae. By two months post-fertilization (mpf), the
average spinal curve was similar in both male and female skolios mutants (Figure 4.2B). In
males, spinal curvature was progressive and by 18 mpf, the average curve was 46° (SD=15.3°),
compared to an average of 28° (SD=14.1°) at 2 mpf (P=0.043, Student’s t-test). Although the
curves were similar at 2 mpf, males developed more severe spinal curves than females at both 7
mpf (36° versus 25°, P=0.042, Student’s t-test) and 18 mpf (46° versus 27°, P=0.037, Student’s
t-test). Female curves were stable and did not change between 2 and 18 mpf. In contrast, curves
measured in WT zebrafish were consistently small, although the spinal curves in males and
females were highly variable. WT zebrafish measured at 2 and 7 mpf had an average spinal
curve of 5.3° (SD=6.7°, N=8) in males and 3.4° (SD=2.1°, N=9) in females (not shown).
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Spinal curvature in skolios mutants occurred in the absence of vertebral fusions or
malformations (Figure 4.2C). Vertebral fusions and malformations were noted in approximately
30% of all skolios mutants, which was comparable to frequencies observed in WT zebrafish
(Figure 4.3).

Meiotic mapping
To localize the gene for skolios, we performed meiotic mapping and narrowed the locus
to a 2-5 Mb region prior to whole genome sequencing. Meiotic mapping localized the mutation
to a region bounded by markers z8980 on one side and either z9692 or z24344 on the other
(z9692 but not z24344 was polymorphic in one WIK fish used for a mapcross, while z24344 but
not z9692 was polymorphic in a second WIK fish used for a mapcross) (Figure 4.4A). The
marker z24344 is not currently listed in Ensembl Zv9 but the sequence can be found in GenBank
(G47401.1) and can subsequently be located in Zv9. The smaller region, between z8980 and
z9692, mapped the phenotype to a 2.7 Mb locus at chr17:47,500,198-50,216,501 (Zv9).

Whole genome sequencing
Although mapping limited the region harboring the mutation responsible for skolios to a
2.7Mb region on chromosome 17, approximately 20 genes remained within the locus. To
simultaneously investigate all genes within the interval, low-coverage whole genome sequencing
was performed on a single skolios mutant. Next generation sequencing reads were aligned to the
Zv9 Tübingen reference genome (Table 4.1). Nearly three-quarters of the reference genome was
covered at ≥3X, which we deemed sufficient to identify a homozygous base change. In the
mapped interval, 18,941 total variants were identified.
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To eliminate strain-specific

polymorphisms resulting from the alignment of skolios (generated on an AB background) to the
Zv9 sequence (Tübingen), variants that were present in sequence data from an unrelated
zebrafish with a similar genetic background (AB) were removed. Only 20 of the remaining
variants were homozygous and caused a nonsynonymous amino acid change. Among these, a
single nonsense mutation was identified, causing a premature stop in kif6 (encoding kinesin
family member 6). The G>T transversion at chr17:48958292 (Zv9) occurs in the second exon of
kif6, which would result in a C>A change in the kif6 mRNA (kif6 is encoded on the minus
strand) and produce premature stop early in the kif6 protein (Figure 4.4B). This variant was
validated in an independent skolios mutant using Sanger sequencing (Figure 4.4C).

TALEN-induced mutations in kif6
Transient knock-down of kif6 with morpholinos targeting the translation start site or the
first exon-intron boundary recapitulated the embryonic curvature defects (Figure 4.5); however,
kif6 morphants developed into normal adults (not shown). Because the transient nature of
morpholinos limits our ability to assess adult phenotypes, we sought to generate stable germline
mutations in kif6 using TALENs (transcription activator-like effector nucleases), which have
been shown to effectively induce new mutations in zebrafish [23]. TALENs are engineered
proteins that can be designed to target a specific DNA sequence and introduce double-stranded
breaks that are repaired through the error-prone nonhomologous end-joining pathway, thus
introducing mutations near the targeted sequence [24].
We designed a TALEN pair targeting a region in the second exon of kif6, which flanked a
BccI restriction site and was adjacent to the G>T transversion at chr17:48958292 (Zv9)
identified in skolios (Figure 4.6A).

TALENs were combined at equal concentrations and
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injected into 1-4 cell stage WT embryos. PCR amplification and subsequent digestion with BccI
showed that all embryos injected with TALENs had some degree of undigested product,
indicating that the BccI restriction site was disrupted by an induced mutation (Figure 4.6B).
Because the F0 (injected) zebrafish are mosaic, zebrafish were outcrossed with WT adults to
create stable lines. Three new mutations were identified in the F1 generation: two different 8 bp
deletions and a 4 bp deletion (Figure 4.6C). Sibling crosses generated F2 zebrafish that were
either homozygous or compound heterozygous for TALEN-induced kif6 mutant alleles. All
combinations produced zebrafish with curvature of the body axis in both embryonic and adult
stages that were indistinguishable from skolios, strongly supporting kif6 as the genetic cause of
skolios (Figure 4.7).

Characterization of kif6 in zebrafish
We performed RT-PCR at various embryonic time points and adult tissues to determine
kif6 expression in WT zebrafish (Figure 4.8). In embryos, kif6 was expressed at low levels
starting at 24 hpf, which were maintained through 120 hpf. In adult tissues, kif6 was expressed
at low levels in brain, intestine, ovary and testis.

Assessment of cilia-related phenotypes in skolios
The function of kif6 is unknown, but it has been predicted to be involved in
cilia/flagellum assembly or function [20,25,26], particularly in ciliated ependymal cells [27].
Several characteristic phenotypes are common in zebrafish with cilia defects (reviewed in
[28,29]), including ventral curvature of the embryo, left-right asymmetry defects, kidney cysts,
hydrocephalus and otolith abnormalities. Because skolios mutants develop embryonic body
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curvature, one of several cilia-related phenotypes, we wondered whether kif6 might be involved
in ciliary assembly/function. To address this we assessed skolios mutants for additional
ciliopathy-related phenotypes. To determine if skolios mutants exhibit an increased incidence of
left-right asymmetry defects, we evaluated the position of the heart in WT and skolios embryos
at 30 hpf (Figure 4.9A). Normal heart positioning was identified in 93.6% of WT embryos
(N=94) and 91.9% of skolios embryos (N=91.9%), suggesting that skolios is not associated with
an increased incidence of left-right asymmetry defects. Similarly, otoliths were evaluated and
WT (N=391) and skolios mutants (N=305) at 48-72 hpf and appeared normal in 98.5% and
98.7%, respectively (Figure 4.9B). Other easily observed phenotypes that are characteristic of
cilia defects, such as hydrocephalus and kidney cysts, were never observed in skolios.
To more closely examine cilia in skolios, we evaluated cilia structure and function in the
central canal.

To evaluate gross ciliary structure, we employed whole-mount confocal

immunostaining using an antibody labelling acetylated tubulin. No gross abnormalities in ciliary
number or morphology were detected in 28 hpf embryos compared to WT (Figure 4.9C). To
evaluate ciliary function, we assessed the movement of dye down the central canal in 48 hpf WT
and skolios embryos using a previously described assay [21]. No differences in dye movement
were observed in skolios mutants compared to WT (Figure 4.9D).
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DISCUSSION

Despite the high frequency of idiopathic scoliosis in humans, the pathogenesis remains
elusive.

Here, we describe a new zebrafish mutant called skolios which develops spinal

deformity that parallels many aspects of human idiopathic scoliosis.
First, skolios mutants develop a complex, three-dimensional curvature of the spine
without the presence of structural vertebral abnormalities. In humans, idiopathic scoliosis is
diagnosed only after other causes of scoliosis have been ruled out, including congenital vertebral
defects or other syndromic diagnoses that can cause scoliosis (e.g. cerebral palsy, Marfan
syndrome). Vertebral defects were noted in some skolios mutants but were present at the same
frequency in WT, suggesting curvature is unlinked to these vertebral abnormalities in skolios
mutants.

Moreover, spinal curvature is the only phenotype observed in skolios mutants,

suggesting that spinal curvature is not occurring secondary to a larger, systemic condition.
Second, like human idiopathic scoliosis, we noted sexual dimorphism in skolios for the
most severe curves. In humans, mild idiopathic scoliosis affects males and females equally, but
females develop severe deformity ten times more frequently than males [30]. In skolios, both
genders were affected, but over time, adult male mutants developed a more severe spinal
deformity compared to adult females. Although this is opposite to the female bias observed in
humans, it nevertheless demonstrates a role for gender in the progression of spinal deformity but
not for overall susceptibility.
Using meiotic mapping and low-coverage whole genome sequencing, we identified a
nonsense mutation in kif6, a poorly characterized member of the kinesin family, as a candidate
mutation for skolios. Our results, along with others [13,31-33], demonstrate that low-coverage
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whole genome sequencing is an effective approach to identify the genetic basis of a zebrafish
mutant. kif6 was confirmed as the causative gene by creating additional mutant alleles using
TALENs that recapitulated both the embryonic and post-embryonic skolios phenotypes.
Kinesins are motor proteins that have diverse function, but can be identified by their highly
conserved motor domain that binds to microtubules and powers movement through the
hydrolysis of ATP. Using degenerate primers designed to this conserved motor domain, kif6 was
first identified in cDNA from mouse hippocampus [34]. In a large mouse cDNA library, kif6
was identified in spinal ganglion and cerebellum [35] and western blotting of mouse tissues has
shown kif6 expression in various tissues, including brain and spinal cord [26]. Our expression
analysis in zebrafish demonstrated similar results, with kif6 expressed in zebrafish brain,
intestine, ovary and testis. To our knowledge, this is the first demonstration of kif6 expression in
zebrafish and the first demonstration of a mutant phenotype resulting from a mutation in kif6.
Kif6 is poorly characterized and its function is unknown. Most investigations of kif6
have been limited to a common single nucleotide polymorphism (rs20455) in humans, which was
associated with coronary artery disease [36-40], although a large meta-analysis failed to replicate
the association [41] and the consequence of the common polymorphism in kif6 is currently being
debated. A kif6 mutant mouse was found to have normal cardiac function, while additional
phenotypes were not described [26]. Kif6 was originally identified as an orphan kinesin [35,42],
but has also been included with kinesin-family member 9 (kif9) in the Kinesin-9 superfamily.
Although kif9 and kif6 share a region of conserved sequence near the kinesin motor domain that
is specific to the Kinesin-9 superfamily [25], the proteins are phylogenetically distant [42].
Members of the Kinesin-9 superfamily have only been identified in vertebrates and protozoa,
which suggests they may be involved in cilia and flagella [25].
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Further evidence for a role of kif6 in cilia was suggested by its downregulation in
forebrain of forkhead box J1 (FoxJ1)-null mice [27], a transcription factor that is necessary and
sufficient for motile cilia generation [43,44]. FoxJ1 is also required for the differentiation of
ependymal cells [17], which are ciliated cells that line the ventricles in the brain and the central
canal in the spinal cord. Ependymal cells are responsible for circulating cerebral spinal fluid,
although they may have additional functions. In the Allen Brain Atlas (http://mouse.brainmap.org/), kif6 expression is limited to the ependymal layer of the ventricle [17] and central
canal of the spinal cord. We did not find gross abnormalities in cilia formation or movement in
the central canal and we did not identify additional cilia related phenotypes in skolios mutants
(defects in left-right asymmetry, otolith abnormalities, hydrocephalus or kidney cysts), however
these findings cannot rule out other cilia-related functions for kif6. Curvature of the body axis is
a common phenotype in zebrafish embryos with cilia defects [28] and has also been observed in
adult cilia mutants [45], which is consistent with a cilia-related defect in skolios. Cilia defects
have been proposed as a mechanism for human idiopathic scoliosis [46], though scoliosis is not a
common in human ciliopathies. Future studies are needed to clarify the function of kif6 and the
mechanism by which it leads to spinal curvature in skolios. It is unclear whether kif6 mutations
are important in the genesis of human idiopathic scoliosis. Efforts aimed at identifying kif6
mutations in a DNA database of pediatric patients with musculoskeletal disorders, including
scoliosis, are currently underway (Christina Gurnett, personal communication).
Overall, this study identifies skolios, a zebrafish mutant with spinal deformity. The
spinal curvature phenotype, which occurs isolated from other features and is not secondary to
vertebral malformations suggests that skolios may serve as a model for human idiopathic
scoliosis, which could be a valuable resource to better understand this complex human condition.
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Moreover, we have established zebrafish as a viable model for spinal deformity that may be of
use to confirm genetic findings in human studies of idiopathic scoliosis. Using meiotic mapping
and whole genome sequencing, we identify kif6 as genetic basis of skolios. These finding
highlight a new role for kif6 in spinal development and stability, expanding upon the already
diverse cellular functions of kinesins.
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Figure 4.1: Skolios mutants develop recessively-inherited curvature of the body axis
(A) Ventral curvature phenotypes observed in skolios embryos at 3 dpf. (B) Relative frequencies
of ventral curvature phenotypes in WT and skolios embryos (3 dpf). (C) Dorsal view of
embryonic (4 dpf) and juvenile (17 dpf) zebrafish showing development of sagittal body
curvature in skolios mutants. (D) Severe body curvature in both the medial-lateral and dorsalventral planes of an adult skolios mutant. (E) MicroCT imaging at approximately 50 dpf shows
marked curvature of the abdominal (rib vertebrae) and caudal (vertebrae posterior to ribs) spine
in skolios mutants.
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Figure 4.2: Spinal curvature in skolios mutants occurs independent of major vertebral
abnormalities and is progressive through adult stages in males
(A) Method of measuring spinal curve in zebrafish using skeletal histomorphology. Lines were
drawn through the middle of the two vertebrae adjacent to the apex of the curve. The measured
angle from the intersection was subtracted from 180° to calculate the spinal curve. (B) Spinal
curves measured for female skolios mutants at 2 (N=11), 5 (N=9), 7 (N=5) and 18 (N=5) mpf
and male skolios mutants at 2 (N=10), 5 (N=8), 7 (N=5) and 18 (N=5) mpf. The average spinal
curve is shown for each time point. At 2 mpf, males and females are similarly affected;
however, by later stages, males continue to progress in severity. *P<0.05. (C) Skeletal
histomorphology of a 2 mpf female WT and a skolios mutant with a 35° spinal curve near the
transition from abdominal to caudal vertebrae that developed in the absence of vertebral fusions
or other major vertebral abnormalities. Box identifies region shown in A.
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Figure 4.3: Vertebral fusions and malformations occur at similar frequencies in skolios and
WT zebrafish
(A) Zebrafish between 2-7 mpf were stained with Alizarin red to visualize individual vertebrae.
Staining shows vertebral fusions (arrows) identified in WT and skolios. (B) The overall
frequency of vertebral fusions in skolios is similar to WT.
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Figure 4.4: Meiotic mapping and whole genome sequencing identifies a nonsense mutation
in kif6 as candidate for skolios
(A) Summary of mapping experiments. Two mapcrosses identified a ~3 Mb region on
chromosome 17 harboring the causative genetic lesion for skolios. (B) Gene and protein
schematic of kif6 with the corresponding location of the nonsense mutation. The G>T mutation
(C>A in mRNA) in the second exon of kif6 causes a premature stop early in the kif6 protein
sequence. Kif6 protein domains are drawn according to the simple modular architecture research
tool (SMART) [47]. The kinesin motor domain is shown, with grey bars indicating coiled-coil
regions. (C) Validation of the G>T mutation in skolios by Sanger sequencing.
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Figure 4.5: Transient knockdown of kif6 using morpholinos
WT zebrafish were injected with morpholinos at the 1-4 cell stage. A morpholino targeting the
kif6 translation start site but containing a 5 base mismatch (mismatch MO) served as a negative
control.
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Figure 4.6: Design and efficiency of kif6 TALENs
(A) Genomic sequence showing left and right TALENs that were designed in the second exon of
kif6 near the site of the nonsense mutation identified in skolios. The TALEN pair flank a BccI
restriction site. (B) BccI restriction digest of PCR amplified DNA from WT embryos. Embryos
1-3 were not injected with kif6 TALENs and BccI cleaves the PCR product completely.
Embryos 4-13 were injected with kif6 TALENs at the 1-4 cell stage and all embryos had varying
levels of uncut product, indicating a mutation was induced at the BccI restriction site. (C) Three
mutations identified in TALEN-injected embryos.

122

Figure 4.7: TALEN-induced mutations in kif6 recapitulate the skolios phenotype
Zebrafish with TALEN-induced mutations in kif6 develop both embryonic and adult body axis
curvature, similar to skolios mutants.
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Figure 4.8: RT-PCR expression of kif6 in WT embryos and adult tissues
(A) RT-PCR in WT zebrafish embryos shows low levels of kif6 between 24-120 hpf. (B) RTPCR of various zebrafish tissues shows kif6 expression primarily in brain, intestine and
reproductive organs.

124

Figure 4.9: Cilia structure and function are normal in skolios mutants
(A) Defects in left-right asymmetry were evaluated by visualizing the position of the heart in 30
hpf embryos for WT (N=94) and skolios mutants (N=173). Normally, zebrafish hearts are
located to the left of the midline (right side when viewed ventrally) at 30 hpf. In zebrafish with
ambiguous heart positioning, hearts appear at the midline and to the right side (left side when
viewed ventrally) in zebrafish with situs inversus. Ambiguous and inversed orientations of the
heart were observed at similar frequencies in WT and skolios embryos. (B) Otoliths were
observed laterally in in 48-72 hpf zebrafish embryos. Normal otolith numbers (two) and
abnormal otolith numbers (one or three) were quantified WT (N=371) and skolios mutants
(N=305). (C) Whole-mount confocal immunostaining of 28 hpf WT and skolios embryos shows
normal appearance of cilial in the central canal (arrows). (D) Live 48 hpf WT and skolios
embryos were injected with 5% tetramethylrhodamine conjugated to 70,000 molecular weight
dextran. Sixty minutes after injection, the dye has migrated similar distances in skolios mutants
compared to WT embryos.
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Table 4.1: Identification of candidate gene using low-coverage
whole genome sequencing
Sequencing and variant identification
101 bp paired-end reads

98,289,069

Aligned paired-end reads

65,990,507

≥3X coverage

74%

Total genomic variants

8,043,651

Variant filtering
Total variants in 2.7 Mb mapped locus

18,941

and absent in unrelated zebrafish with similar
genetic background

4,166

and homozygous

3,156

and causing a nonsynonymous amino acid
change

20

and causing a nonsense mutation (gene)

1 (kif6)
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Discussion and Future Directions
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Scoliosis is a form of spinal deformity that causes the spine to curve abnormally in the
frontal plane.

Although scoliosis occasionally arises as a secondary feature of a broader,

systemic condition, most cases of scoliosis develop in late childhood with no known etiology and
are classified as adolescent idiopathic scoliosis (AIS). AIS is generally a mild condition, but for
unknown reasons, about 10% of AIS patients develop progressive deformity and bracing or
surgery is warranted to prevent negative physical and psychological outcomes. Twin and family
studies indicate a role for genetic factors in AIS development, but the identification of
susceptibility loci using linkage, candidate gene and genome-wide association studies have
yielded mixed and largely inconclusive findings. Overall, the genetic basis of AIS remains
poorly understood, which has been further challenged by the lack of a relevant animal model.
In this dissertation, we explored the role of rare variation in AIS, which had been largely
unaddressed prior to the commencement of this work. Specifically, we evaluated rare copy
number variants (CNVs), chromosomal aneuploidy and rare coding variants (SNPs, INDELs) as
genetic risk factors for AIS. We also proposed that zebrafish (Danio rerio) is an excellent
animal model to identify genetic and molecular pathways involved in spinal development. While
there is still much to be learned about the genetic basis of AIS, several general conclusions can
be drawn from the results of the work presented here that will aid in future efforts to identify
genetic risk factors and better understand AIS.

1. AIS is complex disorder with complex genetics
A major challenge addressing the genetic underpinnings of AIS has been the variable
expressivity of the phenotype. Individuals with AIS have substantial phenotypic variation; curve
severity, age of onset, rates of progression and overall curve morphology can all differ
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significantly among patients. It is unclear to what degree genetic and environmental variation
influences each of these features of AIS and if there are genetic risk factors that modify the AIS
phenotype independent from overall susceptibility.
Our findings support a role for genetic risk factors that act as disease modifiers. In our
exome sequencing study of rare coding variants, we identified rare missense mutations in FBN1
(encoding fibrillin-1) and FBN2 (encoding fibrillin-2) that were strongly associated with curve
severity in AIS patients. These results pose a challenge to future investigations of AIS, as
phenotypic variability among patients could hamper genetic studies by reducing the power of
association or replication studies when case populations are highly heterogeneous. Moreover,
segregation analysis may be misinterpreted in such cases. For example, if a genetic variant
identified in a severely affected AIS patient is absent in a mildly affected family member, the
variant may be deemed unimportant due to the failed segregation, but this result could also be
consistent with the variant being a major disease modifier. The complexity of the AIS phenotype
should therefore be considered when assembling AIS patient cohorts to identify genetic risk
factors for overall AIS susceptibility versus genetic modifiers that contribute to other variable
features of AIS. Because we have shown that genetic modifiers can impact curve severity, it
would be interesting to evaluate other features of AIS that differ among patients (e.g. curve
morphology, rates of progression).
In addition to the interaction between genetic factors and a complex phenotype, we have
also shown that those genetic factors are also complex, with many types of genetic variation
contributing to AIS. Previous genome-wide association studies have addressed the ‘common
disease, common variant’ hypothesis (CDCV) and shown that common variants in LBX1
(encoding ladybird homeobox 1) are associated with AIS in individuals of Asian ancestry [1-4].
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An opposing theory, the ‘common disease, rare variant’ (CDRV) hypothesis, states that common
diseases are due to rare variation of higher penetrance [5]. We show that the CDRV hypothesis
is also a likely disease model for AIS development. In our study of FBN1 and FBN2, we show
that exceedingly rare coding variants were significantly associated with AIS. Similarly, our
analysis of copy number variation identified rare duplications of chromosome 1q21.1 and
trisomy X that were enriched in AIS patients compared to controls.
Collectively, these results indicate that many forms of genetic variation (e.g. CNVs,
missense mutations), both common and rare, are significant genetic factors associated with AIS
susceptibility and/or modifiers of AIS features (e.g. curve severity). Future studies will therefore
need to address multiple forms of genetic variation when evaluating AIS cases and stratify case
populations to reduce heterogeneity.

2. Several genes/loci conferring risk to AIS are

implicated in scoliosis-associated

syndromes
Our results suggest that genes already linked to disorders with high rates of scoliosis are
good candidates for AIS. As previously mentioned, we demonstrated an association with FBN1
and FBN2 in AIS cases with severe deformity. Mutations in FBN1 cause Marfan syndrome [6]
and 63% of Marfan syndrome patients develop scoliosis [7]. However, Marfan syndrome also
causes a variety of other symptoms, including aortic aneurysm and dissections, ectopia lentis, tall
stature, pectus excavatum and carinatum, dolichostenomelia, arachnodactyly and joint
hypermobility. Mutations in FBN2 cause congenital contractural arachnodactyly (also called
Beals syndrome) [8], and 50% of patients develop scoliosis [9], as well as “crumpled” ears,
muscular hypoplasia, contractures of the major joints, pectus excavatum and carinatum, tall
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stature, dolichostenomelia and arachnodactyly. Disease-causing mutations in FBN1 and FBN2
are thought to be highly penetrant and in FBN1, over 1,000 mutations have been described [10].
Because both FBN1 and FBN2 already were linked to Mendelian disorders, it was surprising to
discover an association with FBN1 and FBN2 and AIS. Since Marfan syndrome and congenital
contractural arachnodactyly both lead to scoliosis, we conclude that these specific mutations
confer risk to isolated skeletal phenotypes such as scoliosis without additional disease features.
A comparable finding was observed by Gao et al. [11] in CDH7 (encoding
chromodomain helicase DNA-binding protein 7).

Mutations in CDH7 cause CHARGE

syndrome (coloboma of the eye, heart defects, atresia of the choanae, retardation of growth
and/or development, genital and/or urinary abnormalities, and ear abnormalities and deafness)
[12] and >60% of CHARGE adolescent and adult patients develop scoliosis [11,13]. Sequencing
CDH7 in 25 affected patients with AIS showed the minor allele of a common polymorphism
(rs4738824) was significantly over-transmitted [11]. Although additional studies are needed in a
larger case population to validate these findings, these results are consistent with variants
affecting a gene (CDH7) typically associated with syndromic forms of scoliosis (CHARGE
syndrome) also being a genetic risk factor for AIS.
Similarly, duplications and deletions of 16p11.2 have been recently linked to scoliosis in
individuals with a wide variety of other neurobehavioral and congenital abnormalities [14]. The
16p11.2 locus was also identified by linkage analysis of 202 idiopathic scoliosis families [15,16]
and Al-Kateb et al. [14] hypothesized that 16p11.2 could therefore be a novel susceptibility locus
for idiopathic scoliosis. Prior to the work presented here, 16p11.2 CNVs had not been described
in an individual with isolated scoliosis. We identified a duplication of chromosome 16p11.2 in a
single AIS patient, providing preliminary evidence that 16p11.2 rearrangements can occur in a
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scoliosis patient without the additional neurobehavioral and congenital abnormalities common to
this genomic disorder. Although additional studies containing larger patient cohorts will be
needed to demonstrate an association with 16p11.2 rearrangements and AIS, this finding
supports a role for the 16p11.2 locus in AIS susceptibility, despite causing a genomic disorder
most often associated with many additional phenotypes.
Overall, our findings and others suggest that genes or loci causing systemic diseases
associated with high rates of scoliosis (and many other symptoms) can be involved in the
development of scoliosis as an isolated phenotype.

Future genetic studies of AIS should

therefore focus on genes and molecular pathways associated with neuromuscular or syndromic
forms of scoliosis. For example, scoliosis is common to a number of Mendelian disorders, such
as Ehlers-Danlos syndrome (caused by mutations in collagen genes) [17].

Loeys-Dietz

syndrome is a dominant Mendelian disorder caused by mutations in the transforming growth
factor-beta receptors, TGFβR1 and TGFβR2, that is also highly associated with scoliosis [18].
Because Loeys-Dietz syndrome, like Marfan syndrome and congenital contractural
arachnodactyly, alter the TGF-β pathway, TGFβR1 and TGFβR2 are especially good candidates
to evaluate in future studies.

3. A subset of AIS patients are undiagnosed for other conditions, but this is very rare
In our CNV study, we identified two AIS patients with trisomy of the X chromosome,
also called Triple X syndrome (47,XXX).

Triple X syndrome generally causes only mild

phenotypes, which can include scoliosis [19]. As a result, many females with triple X syndrome
are unaware of the condition [20]. The two females we identified with triple X syndrome
represented <1% of all AIS females we evaluated for CNVs or chromosomal aneuploidy.
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However, discovery of triple X syndrome allows clinicians to monitor other associated
phenotypes (e.g. premature ovarian failure and developmental delay), so this finding is of clinical
relevance despite its rarity.
When we identified patients with rare variants in FBN1, we considered the possibility
that these individuals were undiagnosed for Marfan syndrome.

In some cases, clinical

recognition of Marfan syndrome is challenging due to large phenotypic variability among
patients and nonspecific features. Features that are most specific to Marfan syndrome (e.g. aortic
dilation, ectopia lentis) are only identifiable though testing which is not routinely performed.
Therefore, we referred AIS patients with rare variants in FBN1 for a thorough clinical
examination by a clinical geneticist. One patient with a previously described mutation in FBN1
met the diagnostic criteria for Marfan syndrome after examination, representing only 0.3% of all
AIS patients of European ancestry evaluated (N=311).

Marfan syndrome had not been

previously suspected in this individual, but our finding is likely to be of great impact to the future
health and management of this individual, as 90% of Marfan syndrome patients are affected with
cardiac valve disease, aortic dissection, or congestive heart failure [21].
Generally, the vast majority of AIS patients we evaluated were not found to have genetic
or phenotypic findings suggestive of another diagnosis as a primary cause of scoliosis. However,
we have found that scoliosis can be attributed to a previously undiagnosed, underlying condition
in a very small number of AIS patients. This result was unexpected, as most syndromic forms of
scoliosis occur simultaneously with additional, often easily recognized disease features. Because
many underlying diagnoses necessitate additional clinical care, future clinical and research
studies involving AIS patients should make every attempt to rule out scoliosis-associated
disorders like triple X syndrome and Marfan syndrome that can be difficult to recognize.
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4. Genetic factors may predict AIS patients at risk for severe deformity
Because AIS causes deformity in previously healthy children, a major long-term goal of
AIS research is to identify methods to predict and ultimately prevent severe deformity. One
feasible approach to achieve this would be to identify genetic risk factors for severe deformity
that could inform treatment strategies (e.g. bracing). Idiopathic spinal deformity is common in
the pediatric population, but not all individuals develop severe forms of disease and currently
there is no method of predicting curve progression. As a result, individuals with mild curvatures
may be unnecessarily monitored and treated, whereas treatment may be delayed individuals at
high risk of severe deformity.
We have shown through our evaluation of FBN1 and FBN2 that 7.6% of patients of
European ancestry had a rare variant in either gene and that these variants were significantly
correlated to curve severity in a large cohort of AIS patients of European ancestry (N=405),
which replicated in a cohort of Han Chinese AIS patients (N=370). This indicates that FBN1 and
FBN2 variants may be prognostic genetic markers to predict scoliosis progression and
demonstrates the potential of identifying AIS patients for proactive treatment. More studies will
be needed to assess the clinical value and predictive value of identifying rare fibrillin variants,
but our findings may be an important advance in our ability to identify patients at high risk of
progressive deformity.
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5. Zebrafish may be an ideal model to identify new genes involved in scoliosis/spine
development and model genetic findings in human AIS
A major challenge in understanding AIS has been the lack of a relevant animal model.
Because zebrafish (Danio rerio) are highly tractable and have extensive genomic resources,
zebrafish are particularly well-suited model organisms to model scoliosis.

Another teleost

mutant, the guppy strain curveback, has been shown to develop non-induced spinal deformity
[22], yet, spinal deformity in zebrafish has been largely unexplored. We performed a forward
genetic screen to identify zebrafish mutants with features of AIS. From this screen, we identified
skolios. skolios mutants develop a medial-lateral curvature of the spine that arises independent
of vertebral malformations, similar to humans with AIS. Using meiotic mapping, low-coverage
whole genome sequence and TALENs, we identified kif6 as the genetic basis of skolios.
Overall, these results show that zebrafish are susceptible to AIS-like spinal curvature and
therefore, zebrafish can be used as an animal model for AIS. Our mutagenesis screen (a forward
genetic approach) successfully identified a zebrafish mutant with an AIS-like phenotype. We
confirmed the genetic basis using the many useful tools available in zebrafish. Moreover, these
results suggest that zebrafish are suitable for reverse genetic screens. In future studies, we hope
to induce the genetic changes identified in AIS patients (e.g. FBN1 and FBN2 mutations) to
determine their effect on the spinal column in zebrafish.

In summary, we have provided evidence that rare duplications and deletions are genetic
risk factors for AIS. We have also shown that rare coding variants in FBN1 and FBN2 are
associated with severe deformity and, as there are no reliable methods to predict progression in
AIS patients, we hope these results will aid in our ability to develop future personalized
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prevention strategies that might eliminate the need for surgery in AIS patients at high risk of
severe deformity and to eliminate unnecessary screening and treatment for patients at low risk of
progression. Finally, we have demonstrate zebrafish as a viable animal model to study novel
genetic and molecular pathways involved in spine development and to model genetic findings
uncovered in human AIS populations. The work presented here represents a significant advance
in our understanding of AIS, which will be a primer for future studies aimed at elucidating the
genetic basis and pathogenesis of AIS.
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